<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:media="http://search.yahoo.com/mrss/" version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>clinical trials</title>
		<link>https://biospectrumasia.com/rssfeed/pharma/clinical%20trials</link>
		<atom:link href="https://biospectrumasia.com/rssfeed/pharma/clinical%20trials" rel="self" type="application/rss+xml" />
		<description>clinical trials</description>
					<item>
			<title>Exploring the links between metabolic health, ageing and cancer</title>
			<atom:link href="https://biospectrumasia.com/news/96/28686/exploring-the-links-between-metabolic-health-ageing-and-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28686/exploring-the-links-between-metabolic-health-ageing-and-cancer.html</link>
			<pubDate>Tue, 17 Nov 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/biospectrum_asia_edition__oncology_leaders_300kb-28686.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28686/exploring-the-links-between-metabolic-health-ageing-and-cancer.html</guid>
		</item>	
				<item>
			<title>Advancing hybrid trials: Medidata contributes global perspectives and insights to new SCRI whitepaper in Singapore</title>
			<atom:link href="https://biospectrumasia.com/news/96/28693/advancing-hybrid-trials-medidata-contributes-global-perspectives-and-insights-to-new-scri-whitepaper-in-singapore.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28693/advancing-hybrid-trials-medidata-contributes-global-perspectives-and-insights-to-new-scri-whitepaper-in-singapore.html</link>
			<pubDate>Tue, 17 Nov 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images-28693.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28693/advancing-hybrid-trials-medidata-contributes-global-perspectives-and-insights-to-new-scri-whitepaper-in-singapore.html</guid>
		</item>	
				<item>
			<title>L’Oréal-UNESCO For Women in Science awards emerging Singapore researchers shaping the future of science</title>
			<atom:link href="https://biospectrumasia.com/news/96/28653/loral-unesco-for-women-in-science-awards-emerging-singapore-researchers-shaping-the-future-of-science.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28653/loral-unesco-for-women-in-science-awards-emerging-singapore-researchers-shaping-the-future-of-science.html</link>
			<pubDate>Fri, 06 Nov 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/img_300kb-28653.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28653/loral-unesco-for-women-in-science-awards-emerging-singapore-researchers-shaping-the-future-of-science.html</guid>
		</item>	
				<item>
			<title>CellProthera selected for JETRO’s Japan Entry Acceleration Program</title>
			<atom:link href="https://biospectrumasia.com/news/96/28631/cellprothera-selected-for-jetros-japan-entry-acceleration-program.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28631/cellprothera-selected-for-jetros-japan-entry-acceleration-program.html</link>
			<pubDate>Tue, 03 Nov 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1200x680-28631.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28631/cellprothera-selected-for-jetros-japan-entry-acceleration-program.html</guid>
		</item>	
				<item>
			<title>Illumina selected to help bring precision medicine into everyday healthcare in Singapore</title>
			<atom:link href="https://biospectrumasia.com/news/96/28634/illumina-selected-to-help-bring-precision-medicine-into-everyday-healthcare-in-singapore.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28634/illumina-selected-to-help-bring-precision-medicine-into-everyday-healthcare-in-singapore.html</link>
			<pubDate>Tue, 03 Nov 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/unnamed-28634.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28634/illumina-selected-to-help-bring-precision-medicine-into-everyday-healthcare-in-singapore.html</guid>
		</item>	
				<item>
			<title>Stem-Cell Therapies Are No Longer a Distant Promise — The Real Challenge Is Delivering Lasting Results</title>
			<atom:link href="https://biospectrumasia.com/analysis/96/28607/stem-cell-therapies-are-no-longer-a-distant-promise-the-real-challenge-is-delivering-lasting-results.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/96/28607/stem-cell-therapies-are-no-longer-a-distant-promise-the-real-challenge-is-delivering-lasting-results.html</link>
			<pubDate>Thu, 29 Oct 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download_1-28607.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/96/28607/stem-cell-therapies-are-no-longer-a-distant-promise-the-real-challenge-is-delivering-lasting-results.html</guid>
		</item>	
				<item>
			<title>Abu Dhabi and Novartis activate Clinical Trials Hub through global Phase 3 programmes</title>
			<atom:link href="https://biospectrumasia.com/news/96/28596/abu-dhabi-and-novartis-activate-clinical-trials-hub-through-global-phase-3-programmes.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28596/abu-dhabi-and-novartis-activate-clinical-trials-hub-through-global-phase-3-programmes.html</link>
			<pubDate>Wed, 28 Oct 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_28_10_2026_161948_www_zawya_com-28596.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28596/abu-dhabi-and-novartis-activate-clinical-trials-hub-through-global-phase-3-programmes.html</guid>
		</item>	
				<item>
			<title>Shionogi and F2G report Phase 3 results for oral antifungal olorofim</title>
			<atom:link href="https://biospectrumasia.com/news/96/28570/shionogi-and-f2g-report-phase-3-results-for-oral-antifungal-olorofim.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28570/shionogi-and-f2g-report-phase-3-results-for-oral-antifungal-olorofim.html</link>
			<pubDate>Thu, 22 Oct 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images-28570.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28570/shionogi-and-f2g-report-phase-3-results-for-oral-antifungal-olorofim.html</guid>
		</item>	
				<item>
			<title>Asia should help design global clinical trials, Not simply enroll in them</title>
			<atom:link href="https://biospectrumasia.com/opinion/96/28545/asia-should-help-design-global-clinical-trials-not-simply-enroll-in-them.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/96/28545/asia-should-help-design-global-clinical-trials-not-simply-enroll-in-them.html</link>
			<pubDate>Mon, 19 Oct 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-28545.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/96/28545/asia-should-help-design-global-clinical-trials-not-simply-enroll-in-them.html</guid>
		</item>	
				<item>
			<title>AtomVie inks strategic partnership with Jubilant Radiopharma to strengthen logistics and distribution in Clinical Trials</title>
			<atom:link href="https://biospectrumasia.com/news/96/28537/atomvie-inks-strategic-partnership-with-jubilant-radiopharma-to-strengthen-logistics-and-distribution-in-clinical-trials.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28537/atomvie-inks-strategic-partnership-with-jubilant-radiopharma-to-strengthen-logistics-and-distribution-in-clinical-trials.html</link>
			<pubDate>Fri, 16 Oct 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_16_10_2026_134431_www_jubilantradiopharma_com-28537.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28537/atomvie-inks-strategic-partnership-with-jubilant-radiopharma-to-strengthen-logistics-and-distribution-in-clinical-trials.html</guid>
		</item>	
				<item>
			<title>Korea&#039;s GCCL signs MoU with LabConnect to expand global clinical trial collaboration</title>
			<atom:link href="https://biospectrumasia.com/news/96/28518/koreas-gccl-signs-mou-with-labconnect-to-expand-global-clinical-trial-collaboration.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28518/koreas-gccl-signs-mou-with-labconnect-to-expand-global-clinical-trial-collaboration.html</link>
			<pubDate>Tue, 13 Oct 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_13_10_2026_101232_en_prnasia_com-28518.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28518/koreas-gccl-signs-mou-with-labconnect-to-expand-global-clinical-trial-collaboration.html</guid>
		</item>	
				<item>
			<title>AI drug discovery must deliver repeatable value beyond hype: Insilico Medicine’s Feng Ren</title>
			<atom:link href="https://biospectrumasia.com/opinion/96/28519/ai-drug-discovery-must-deliver-repeatable-value-beyond-hype-insilico-medicines-feng-ren.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/96/28519/ai-drug-discovery-must-deliver-repeatable-value-beyond-hype-insilico-medicines-feng-ren.html</link>
			<pubDate>Tue, 13 Oct 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dr_feng_ren_2_300kb-28519.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/96/28519/ai-drug-discovery-must-deliver-repeatable-value-beyond-hype-insilico-medicines-feng-ren.html</guid>
		</item>	
				<item>
			<title>Everest Medicines announces NMPA acceptance of LEROCHOL BLA for hypercholesterolemia</title>
			<atom:link href="https://biospectrumasia.com/news/96/28506/everest-medicines-announces-nmpa-acceptance-of-lerochol-bla-for-hypercholesterolemia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28506/everest-medicines-announces-nmpa-acceptance-of-lerochol-bla-for-hypercholesterolemia.html</link>
			<pubDate>Mon, 12 Oct 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/everest_medicines_500-28506.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28506/everest-medicines-announces-nmpa-acceptance-of-lerochol-bla-for-hypercholesterolemia.html</guid>
		</item>	
				<item>
			<title>Everest Medicines announces NMPA acceptance of LEROCHOL BLA for hypercholesterolemia</title>
			<atom:link href="https://biospectrumasia.com/news/96/28507/everest-medicines-announces-nmpa-acceptance-of-lerochol-bla-for-hypercholesterolemia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28507/everest-medicines-announces-nmpa-acceptance-of-lerochol-bla-for-hypercholesterolemia.html</link>
			<pubDate>Mon, 12 Oct 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/everest_medicines_500-28507.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28507/everest-medicines-announces-nmpa-acceptance-of-lerochol-bla-for-hypercholesterolemia.html</guid>
		</item>	
				<item>
			<title>IASO Bio receives FDA IND clearance for CD20-targeted in vivo CAR-T therapy</title>
			<atom:link href="https://biospectrumasia.com/news/96/28396/iaso-bio-receives-fda-ind-clearance-for-cd20-targeted-in-vivo-car-t-therapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28396/iaso-bio-receives-fda-ind-clearance-for-cd20-targeted-in-vivo-car-t-therapy.html</link>
			<pubDate>Fri, 18 Sep 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images_1_-28396.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28396/iaso-bio-receives-fda-ind-clearance-for-cd20-targeted-in-vivo-car-t-therapy.html</guid>
		</item>	
				<item>
			<title>Akeso receives China Phase I clearance for EGFR/TROP2 bispecific ADC AK158D1</title>
			<atom:link href="https://biospectrumasia.com/news/96/28397/akeso-receives-china-phase-i-clearance-for-egfr-trop2-bispecific-adc-ak158d1.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28397/akeso-receives-china-phase-i-clearance-for-egfr-trop2-bispecific-adc-ak158d1.html</link>
			<pubDate>Fri, 18 Sep 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images_2_-28397.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28397/akeso-receives-china-phase-i-clearance-for-egfr-trop2-bispecific-adc-ak158d1.html</guid>
		</item>	
				<item>
			<title>J&amp;J reports longest median overall survival with RYBREVANT plus chemotherapy in EGFR exon 20 insertion NSCLC</title>
			<atom:link href="https://biospectrumasia.com/news/96/28372/jj-reports-longest-median-overall-survival-with-rybrevant-plus-chemotherapy-in-egfr-exon-20-insertion-nsclc.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28372/jj-reports-longest-median-overall-survival-with-rybrevant-plus-chemotherapy-in-egfr-exon-20-insertion-nsclc.html</link>
			<pubDate>Tue, 15 Sep 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download-28372.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28372/jj-reports-longest-median-overall-survival-with-rybrevant-plus-chemotherapy-in-egfr-exon-20-insertion-nsclc.html</guid>
		</item>	
				<item>
			<title>Kelun-Biotech reports Phase III benefit for trastuzumab botidotin in HER2-positive breast cancer</title>
			<atom:link href="https://biospectrumasia.com/news/96/28373/kelun-biotech-reports-phase-iii-benefit-for-trastuzumab-botidotin-in-her2-positive-breast-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28373/kelun-biotech-reports-phase-iii-benefit-for-trastuzumab-botidotin-in-her2-positive-breast-cancer.html</link>
			<pubDate>Tue, 15 Sep 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/logo_kelun_biotech_logo-28373.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28373/kelun-biotech-reports-phase-iii-benefit-for-trastuzumab-botidotin-in-her2-positive-breast-cancer.html</guid>
		</item>	
				<item>
			<title>Minoryx and Neuraxpharm complete enrolment in Phase III CALYX trial of leriglitazone</title>
			<atom:link href="https://biospectrumasia.com/news/96/28356/minoryx-and-neuraxpharm-complete-enrolment-in-phase-iii-calyx-trial-of-leriglitazone.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28356/minoryx-and-neuraxpharm-complete-enrolment-in-phase-iii-calyx-trial-of-leriglitazone.html</link>
			<pubDate>Thu, 10 Sep 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images-28356.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28356/minoryx-and-neuraxpharm-complete-enrolment-in-phase-iii-calyx-trial-of-leriglitazone.html</guid>
		</item>	
				<item>
			<title>Alebund receives FDA clearance to advance first-in-class AP308 into IgA nephropathy trial</title>
			<atom:link href="https://biospectrumasia.com/news/96/28341/alebund-receives-fda-clearance-to-advance-first-in-class-ap308-into-iga-nephropathy-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28341/alebund-receives-fda-clearance-to-advance-first-in-class-ap308-into-iga-nephropathy-trial.html</link>
			<pubDate>Wed, 09 Sep 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images-28341.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28341/alebund-receives-fda-clearance-to-advance-first-in-class-ap308-into-iga-nephropathy-trial.html</guid>
		</item>	
				<item>
			<title>Kelun-Biotech partner advances ultra-long-acting asthma antibody into Phase III</title>
			<atom:link href="https://biospectrumasia.com/news/96/28342/kelun-biotech-partner-advances-ultra-long-acting-asthma-antibody-into-phase-iii.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28342/kelun-biotech-partner-advances-ultra-long-acting-asthma-antibody-into-phase-iii.html</link>
			<pubDate>Wed, 09 Sep 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/logo_kelun_biotech_logo_28139-28342.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28342/kelun-biotech-partner-advances-ultra-long-acting-asthma-antibody-into-phase-iii.html</guid>
		</item>	
				<item>
			<title>Ascletis starts US Phase I trial of oral amylin agonist ASC36 for obesity</title>
			<atom:link href="https://biospectrumasia.com/news/96/28343/ascletis-starts-us-phase-i-trial-of-oral-amylin-agonist-asc36-for-obesity.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28343/ascletis-starts-us-phase-i-trial-of-oral-amylin-agonist-asc36-for-obesity.html</link>
			<pubDate>Wed, 09 Sep 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/5fd2c260_21c0_11ef_ad1f_e33a28dd5e74_ascletis_company_logo-28343.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28343/ascletis-starts-us-phase-i-trial-of-oral-amylin-agonist-asc36-for-obesity.html</guid>
		</item>	
				<item>
			<title>Accro and Fosun advance oral TYK2/JAK1 inhibitor AC-201 into China Phase II/III vitiligo trial</title>
			<atom:link href="https://biospectrumasia.com/news/96/28344/accro-and-fosun-advance-oral-tyk2-jak1-inhibitor-ac-201-into-china-phase-ii-iii-vitiligo-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28344/accro-and-fosun-advance-oral-tyk2-jak1-inhibitor-ac-201-into-china-phase-ii-iii-vitiligo-trial.html</link>
			<pubDate>Wed, 09 Sep 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images_1_-28344.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28344/accro-and-fosun-advance-oral-tyk2-jak1-inhibitor-ac-201-into-china-phase-ii-iii-vitiligo-trial.html</guid>
		</item>	
				<item>
			<title>Singapore strengthens clinical trials capacity in collaboration with WHO</title>
			<atom:link href="https://biospectrumasia.com/news/96/28336/singapore-strengthens-clinical-trials-capacity-in-collaboration-with-who.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28336/singapore-strengthens-clinical-trials-capacity-in-collaboration-with-who.html</link>
			<pubDate>Tue, 08 Sep 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_8_9_2026_11958_www_who_int-28336.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28336/singapore-strengthens-clinical-trials-capacity-in-collaboration-with-who.html</guid>
		</item>	
				<item>
			<title>DHL Express partners Life Science Incubator to support Singapore life sciences ecosystem</title>
			<atom:link href="https://biospectrumasia.com/news/96/28323/dhl-express-partners-life-science-incubator-to-support-singapore-life-sciences-ecosystem.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28323/dhl-express-partners-life-science-incubator-to-support-singapore-life-sciences-ecosystem.html</link>
			<pubDate>Mon, 07 Sep 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cargo_plane_takes_off_0001-28323.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28323/dhl-express-partners-life-science-incubator-to-support-singapore-life-sciences-ecosystem.html</guid>
		</item>	
				<item>
			<title>FedEx Singapore Life Science Center strengthens healthcare distribution across Asia Pacific</title>
			<atom:link href="https://biospectrumasia.com/news/96/28324/fedex-singapore-life-science-center-strengthens-healthcare-distribution-across-asia-pacific.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28324/fedex-singapore-life-science-center-strengthens-healthcare-distribution-across-asia-pacific.html</link>
			<pubDate>Mon, 07 Sep 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fedex_photo_124968474_business_grzegorz_kieca_dreamstime_com_-28324.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28324/fedex-singapore-life-science-center-strengthens-healthcare-distribution-across-asia-pacific.html</guid>
		</item>	
				<item>
			<title>DHL expands life sciences and healthcare logistics infrastructure in Singapore</title>
			<atom:link href="https://biospectrumasia.com/news/96/28333/dhl-expands-life-sciences-and-healthcare-logistics-infrastructure-in-singapore.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28333/dhl-expands-life-sciences-and-healthcare-logistics-infrastructure-in-singapore.html</link>
			<pubDate>Mon, 07 Sep 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dhl_pharma_hub_cold_chain-28333.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28333/dhl-expands-life-sciences-and-healthcare-logistics-infrastructure-in-singapore.html</guid>
		</item>	
				<item>
			<title>CMS wins China approval for Lumirix in mild-to-moderate atopic dermatitis</title>
			<atom:link href="https://biospectrumasia.com/news/96/28334/cms-wins-china-approval-for-lumirix-in-mild-to-moderate-atopic-dermatitis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28334/cms-wins-china-approval-for-lumirix-in-mild-to-moderate-atopic-dermatitis.html</link>
			<pubDate>Mon, 07 Sep 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_1096459574_750x406-28334.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28334/cms-wins-china-approval-for-lumirix-in-mild-to-moderate-atopic-dermatitis.html</guid>
		</item>	
				<item>
			<title>Everest Medicines wins China approval for CARDAMYST in acute PSVT</title>
			<atom:link href="https://biospectrumasia.com/news/96/28335/everest-medicines-wins-china-approval-for-cardamyst-in-acute-psvt.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28335/everest-medicines-wins-china-approval-for-cardamyst-in-acute-psvt.html</link>
			<pubDate>Mon, 07 Sep 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images-28335.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28335/everest-medicines-wins-china-approval-for-cardamyst-in-acute-psvt.html</guid>
		</item>	
				<item>
			<title>Singapore becomes first ASEAN market to subsidise vutrisiran for transthyretin amyloidosis</title>
			<atom:link href="https://biospectrumasia.com/news/96/28304/singapore-becomes-first-asean-market-to-subsidise-vutrisiran-for-transthyretin-amyloidosis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28304/singapore-becomes-first-asean-market-to-subsidise-vutrisiran-for-transthyretin-amyloidosis.html</link>
			<pubDate>Wed, 02 Sep 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images-28304.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28304/singapore-becomes-first-asean-market-to-subsidise-vutrisiran-for-transthyretin-amyloidosis.html</guid>
		</item>	
				<item>
			<title>Singapore expands subsidised access to Roche’s Columvi for relapsed or refractory DLBCL</title>
			<atom:link href="https://biospectrumasia.com/news/96/28305/singapore-expands-subsidised-access-to-roches-columvi-for-relapsed-or-refractory-dlbcl.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28305/singapore-expands-subsidised-access-to-roches-columvi-for-relapsed-or-refractory-dlbcl.html</link>
			<pubDate>Wed, 02 Sep 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images_1_-28305.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28305/singapore-expands-subsidised-access-to-roches-columvi-for-relapsed-or-refractory-dlbcl.html</guid>
		</item>	
				<item>
			<title>Ascletis doses first participant in global Phase III trial of oral GLP-1 candidate ASC30</title>
			<atom:link href="https://biospectrumasia.com/news/96/28306/ascletis-doses-first-participant-in-global-phase-iii-trial-of-oral-glp-1-candidate-asc30.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28306/ascletis-doses-first-participant-in-global-phase-iii-trial-of-oral-glp-1-candidate-asc30.html</link>
			<pubDate>Wed, 02 Sep 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images-28306.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28306/ascletis-doses-first-participant-in-global-phase-iii-trial-of-oral-glp-1-candidate-asc30.html</guid>
		</item>	
				<item>
			<title>Fosun Pharma strengthens innovation pipeline as Henlius and global drug portfolio expand</title>
			<atom:link href="https://biospectrumasia.com/news/96/28285/fosun-pharma-strengthens-innovation-pipeline-as-henlius-and-global-drug-portfolio-expand.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28285/fosun-pharma-strengthens-innovation-pipeline-as-henlius-and-global-drug-portfolio-expand.html</link>
			<pubDate>Mon, 31 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images_2-28285.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28285/fosun-pharma-strengthens-innovation-pipeline-as-henlius-and-global-drug-portfolio-expand.html</guid>
		</item>	
				<item>
			<title>DualityBio and Genentech partner on next-generation ADCs in deal worth over $1 billion</title>
			<atom:link href="https://biospectrumasia.com/news/96/28287/dualitybio-and-genentech-partner-on-next-generation-adcs-in-deal-worth-over-1-billion.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28287/dualitybio-and-genentech-partner-on-next-generation-adcs-in-deal-worth-over-1-billion.html</link>
			<pubDate>Mon, 31 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_1967211931_header_1024x360-28287.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28287/dualitybio-and-genentech-partner-on-next-generation-adcs-in-deal-worth-over-1-billion.html</guid>
		</item>	
				<item>
			<title>Formosa Pharma files European trial application for Kadcyla biosimilar TSY-110</title>
			<atom:link href="https://biospectrumasia.com/news/96/28288/formosa-pharma-files-european-trial-application-for-kadcyla-biosimilar-tsy-110.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28288/formosa-pharma-files-european-trial-application-for-kadcyla-biosimilar-tsy-110.html</link>
			<pubDate>Mon, 31 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images-28288.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28288/formosa-pharma-files-european-trial-application-for-kadcyla-biosimilar-tsy-110.html</guid>
		</item>	
				<item>
			<title>Longevity Life Sciences partners Mitsubishi Gas Chemical to expand cellular health platform</title>
			<atom:link href="https://biospectrumasia.com/news/96/28279/longevity-life-sciences-partners-mitsubishi-gas-chemical-to-expand-cellular-health-platform.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28279/longevity-life-sciences-partners-mitsubishi-gas-chemical-to-expand-cellular-health-platform.html</link>
			<pubDate>Fri, 28 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/lls_mgc_partnership-28279.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28279/longevity-life-sciences-partners-mitsubishi-gas-chemical-to-expand-cellular-health-platform.html</guid>
		</item>	
				<item>
			<title>Kazia reports 100% clinical benefit rate in initial patients with advanced triple-negative breast cancer</title>
			<atom:link href="https://biospectrumasia.com/news/96/28280/kazia-reports-100-clinical-benefit-rate-in-initial-patients-with-advanced-triple-negative-breast-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28280/kazia-reports-100-clinical-benefit-rate-in-initial-patients-with-advanced-triple-negative-breast-cancer.html</link>
			<pubDate>Fri, 28 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images-28280.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28280/kazia-reports-100-clinical-benefit-rate-in-initial-patients-with-advanced-triple-negative-breast-cancer.html</guid>
		</item>	
				<item>
			<title>Antengene receives Australian clearance for Phase I ATG-201 autoimmune disease trial</title>
			<atom:link href="https://biospectrumasia.com/news/96/28282/antengene-receives-australian-clearance-for-phase-i-atg-201-autoimmune-disease-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28282/antengene-receives-australian-clearance-for-phase-i-atg-201-autoimmune-disease-trial.html</link>
			<pubDate>Fri, 28 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images-28282.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28282/antengene-receives-australian-clearance-for-phase-i-atg-201-autoimmune-disease-trial.html</guid>
		</item>	
				<item>
			<title>Alebund advances renal pipeline as AP301 enters China regulatory review</title>
			<atom:link href="https://biospectrumasia.com/news/96/28283/alebund-advances-renal-pipeline-as-ap301-enters-china-regulatory-review.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28283/alebund-advances-renal-pipeline-as-ap301-enters-china-regulatory-review.html</link>
			<pubDate>Fri, 28 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1736499971658-28283.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28283/alebund-advances-renal-pipeline-as-ap301-enters-china-regulatory-review.html</guid>
		</item>	
				<item>
			<title>First patient dosed in Australian KOALA CAR-T trial for multiple myeloma</title>
			<atom:link href="https://biospectrumasia.com/news/96/28264/first-patient-dosed-in-australian-koala-car-t-trial-for-multiple-myeloma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28264/first-patient-dosed-in-australian-koala-car-t-trial-for-multiple-myeloma.html</link>
			<pubDate>Thu, 27 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/celltherapies_inside_hood-28264.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28264/first-patient-dosed-in-australian-koala-car-t-trial-for-multiple-myeloma.html</guid>
		</item>	
				<item>
			<title>CStone secures China IND approval for EGFR/HER3 bispecific ADC CS5007</title>
			<atom:link href="https://biospectrumasia.com/news/96/28247/cstone-secures-china-ind-approval-for-egfr-her3-bispecific-adc-cs5007.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28247/cstone-secures-china-ind-approval-for-egfr-her3-bispecific-adc-cs5007.html</link>
			<pubDate>Mon, 24 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cstone_pharma-28247.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28247/cstone-secures-china-ind-approval-for-egfr-her3-bispecific-adc-cs5007.html</guid>
		</item>	
				<item>
			<title>CureGene doses first participant in Phase I trial of liver-targeting CG-0416</title>
			<atom:link href="https://biospectrumasia.com/news/96/28248/curegene-doses-first-participant-in-phase-i-trial-of-liver-targeting-cg-0416.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28248/curegene-doses-first-participant-in-phase-i-trial-of-liver-targeting-cg-0416.html</link>
			<pubDate>Mon, 24 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images_2_-28248.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28248/curegene-doses-first-participant-in-phase-i-trial-of-liver-targeting-cg-0416.html</guid>
		</item>	
				<item>
			<title>Leads Biolabs’ opamtistomig NDA accepted in China for neuroendocrine carcinoma</title>
			<atom:link href="https://biospectrumasia.com/news/96/28249/leads-biolabs-opamtistomig-nda-accepted-in-china-for-neuroendocrine-carcinoma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28249/leads-biolabs-opamtistomig-nda-accepted-in-china-for-neuroendocrine-carcinoma.html</link>
			<pubDate>Mon, 24 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images-28249.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28249/leads-biolabs-opamtistomig-nda-accepted-in-china-for-neuroendocrine-carcinoma.html</guid>
		</item>	
				<item>
			<title>Akeso receives China clinical trial clearance for B7-H3 ADC AK157D1</title>
			<atom:link href="https://biospectrumasia.com/news/96/28250/akeso-receives-china-clinical-trial-clearance-for-b7-h3-adc-ak157d1.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28250/akeso-receives-china-clinical-trial-clearance-for-b7-h3-adc-ak157d1.html</link>
			<pubDate>Mon, 24 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/updated_akeso_logo_2_3-28250.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28250/akeso-receives-china-clinical-trial-clearance-for-b7-h3-adc-ak157d1.html</guid>
		</item>	
				<item>
			<title>GSK’s Blenrep combinations approved in Singapore for relapsed or refractory multiple myeloma</title>
			<atom:link href="https://biospectrumasia.com/news/96/28238/gsks-blenrep-combinations-approved-in-singapore-for-relapsed-or-refractory-multiple-myeloma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28238/gsks-blenrep-combinations-approved-in-singapore-for-relapsed-or-refractory-multiple-myeloma.html</link>
			<pubDate>Fri, 21 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/gsk_in_singapore-28238.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28238/gsks-blenrep-combinations-approved-in-singapore-for-relapsed-or-refractory-multiple-myeloma.html</guid>
		</item>	
				<item>
			<title>Brii Biosciences advances mRNA cancer vaccine into clinical evaluation for liver cancer</title>
			<atom:link href="https://biospectrumasia.com/news/96/28239/brii-biosciences-advances-mrna-cancer-vaccine-into-clinical-evaluation-for-liver-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28239/brii-biosciences-advances-mrna-cancer-vaccine-into-clinical-evaluation-for-liver-cancer.html</link>
			<pubDate>Fri, 21 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/brii-28239.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28239/brii-biosciences-advances-mrna-cancer-vaccine-into-clinical-evaluation-for-liver-cancer.html</guid>
		</item>	
				<item>
			<title>Telix advances radiopharmaceutical pipeline as H1 revenue reaches $477 million</title>
			<atom:link href="https://biospectrumasia.com/news/96/28240/telix-advances-radiopharmaceutical-pipeline-as-h1-revenue-reaches-477-million.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28240/telix-advances-radiopharmaceutical-pipeline-as-h1-revenue-reaches-477-million.html</link>
			<pubDate>Fri, 21 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/telix_main_logo__1_-28240.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28240/telix-advances-radiopharmaceutical-pipeline-as-h1-revenue-reaches-477-million.html</guid>
		</item>	
				<item>
			<title>Brown University Health and Arcamyra to launch Phase I trial of ACM-CpG in peritoneal carcinomatosis</title>
			<atom:link href="https://biospectrumasia.com/news/96/28229/brown-university-health-and-arcamyra-to-launch-phase-i-trial-of-acm-cpg-in-peritoneal-carcinomatosis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28229/brown-university-health-and-arcamyra-to-launch-phase-i-trial-of-acm-cpg-in-peritoneal-carcinomatosis.html</link>
			<pubDate>Thu, 20 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/26765_brown_university_health_logo-28229.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28229/brown-university-health-and-arcamyra-to-launch-phase-i-trial-of-acm-cpg-in-peritoneal-carcinomatosis.html</guid>
		</item>	
				<item>
			<title>CanSinoBIO’s Td5cp adolescent and adult vaccine NDA accepted in China</title>
			<atom:link href="https://biospectrumasia.com/news/96/28223/cansinobios-td5cp-adolescent-and-adult-vaccine-nda-accepted-in-china.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28223/cansinobios-td5cp-adolescent-and-adult-vaccine-nda-accepted-in-china.html</link>
			<pubDate>Wed, 19 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/logo_cansinobio-28223.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28223/cansinobios-td5cp-adolescent-and-adult-vaccine-nda-accepted-in-china.html</guid>
		</item>	
				<item>
			<title>Everest Medicines’ LEROCHOL BLA accepted in China for hypercholesterolemia</title>
			<atom:link href="https://biospectrumasia.com/news/96/28214/everest-medicines-lerochol-bla-accepted-in-china-for-hypercholesterolemia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28214/everest-medicines-lerochol-bla-accepted-in-china-for-hypercholesterolemia.html</link>
			<pubDate>Tue, 18 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/everest_medicines_500-28214.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28214/everest-medicines-lerochol-bla-accepted-in-china-for-hypercholesterolemia.html</guid>
		</item>	
				<item>
			<title>CDISC China Interchange focuses on AI-enabled workflows and clinical research data standards</title>
			<atom:link href="https://biospectrumasia.com/news/96/28202/cdisc-china-interchange-focuses-on-ai-enabled-workflows-and-clinical-research-data-standards.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28202/cdisc-china-interchange-focuses-on-ai-enabled-workflows-and-clinical-research-data-standards.html</link>
			<pubDate>Mon, 17 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mak_0377_3_2-28202.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28202/cdisc-china-interchange-focuses-on-ai-enabled-workflows-and-clinical-research-data-standards.html</guid>
		</item>	
				<item>
			<title>Ascletis begins two US Phase I studies of once-monthly obesity candidates</title>
			<atom:link href="https://biospectrumasia.com/news/96/28191/ascletis-begins-two-us-phase-i-studies-of-once-monthly-obesity-candidates.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28191/ascletis-begins-two-us-phase-i-studies-of-once-monthly-obesity-candidates.html</link>
			<pubDate>Thu, 13 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images_6_-28191.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28191/ascletis-begins-two-us-phase-i-studies-of-once-monthly-obesity-candidates.html</guid>
		</item>	
				<item>
			<title>Phase III trial finds high-dose vitamin D does not improve colorectal cancer outcomes</title>
			<atom:link href="https://biospectrumasia.com/news/96/28155/phase-iii-trial-finds-high-dose-vitamin-d-does-not-improve-colorectal-cancer-outcomes.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28155/phase-iii-trial-finds-high-dose-vitamin-d-does-not-improve-colorectal-cancer-outcomes.html</link>
			<pubDate>Wed, 05 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/69b1216fc5bf238c2de3b51a_doctor_looking_at_brain_scans-28155.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28155/phase-iii-trial-finds-high-dose-vitamin-d-does-not-improve-colorectal-cancer-outcomes.html</guid>
		</item>	
				<item>
			<title>ArkBio completes cohort dosing in Australian Phase I trial of influenza candidate AK0406</title>
			<atom:link href="https://biospectrumasia.com/news/96/28147/arkbio-completes-cohort-dosing-in-australian-phase-i-trial-of-influenza-candidate-ak0406.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28147/arkbio-completes-cohort-dosing-in-australian-phase-i-trial-of-influenza-candidate-ak0406.html</link>
			<pubDate>Tue, 04 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/oc4jrpdtydsauabcnsdapsscuba1770104576934_200x200-28147.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28147/arkbio-completes-cohort-dosing-in-australian-phase-i-trial-of-influenza-candidate-ak0406.html</guid>
		</item>	
				<item>
			<title>Kelun-Biotech receives China clearance to begin clinical development of dual-payload ADC</title>
			<atom:link href="https://biospectrumasia.com/news/96/28139/kelun-biotech-receives-china-clearance-to-begin-clinical-development-of-dual-payload-adc.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28139/kelun-biotech-receives-china-clearance-to-begin-clinical-development-of-dual-payload-adc.html</link>
			<pubDate>Mon, 03 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/logo_kelun_biotech_logo-28139.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28139/kelun-biotech-receives-china-clearance-to-begin-clinical-development-of-dual-payload-adc.html</guid>
		</item>	
				<item>
			<title>Harbour BioMed and Kelun-Biotech receive China IND approval for bispecific asthma therapy</title>
			<atom:link href="https://biospectrumasia.com/news/96/28141/harbour-biomed-and-kelun-biotech-receive-china-ind-approval-for-bispecific-asthma-therapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28141/harbour-biomed-and-kelun-biotech-receive-china-ind-approval-for-bispecific-asthma-therapy.html</link>
			<pubDate>Mon, 03 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hb_for_email_logo-28141.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28141/harbour-biomed-and-kelun-biotech-receive-china-ind-approval-for-bispecific-asthma-therapy.html</guid>
		</item>	
				<item>
			<title>“Thailand’s competitive strength lies in its ability to consistently deliver high-quality clinical trials at scale” </title>
			<atom:link href="https://biospectrumasia.com/opinion/96/28132/thailands-competitive-strength-lies-in-its-ability-to-consistently-deliver-high-quality-clinical-trials-at-scale-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/96/28132/thailands-competitive-strength-lies-in-its-ability-to-consistently-deliver-high-quality-clinical-trials-at-scale-.html</link>
			<pubDate>Sat, 01 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/angkana_prapakorn-28132.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/96/28132/thailands-competitive-strength-lies-in-its-ability-to-consistently-deliver-high-quality-clinical-trials-at-scale-.html</guid>
		</item>	
				<item>
			<title>Singapore strengthens position as premier clinical research hub</title>
			<atom:link href="https://biospectrumasia.com/news/96/28125/singapore-strengthens-position-as-premier-clinical-research-hub.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28125/singapore-strengthens-position-as-premier-clinical-research-hub.html</link>
			<pubDate>Thu, 30 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mou_signing_astrazeneca_az_cris_nhg_health_national_university_health_system_nuhs_and_singhealth-28125.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28125/singapore-strengthens-position-as-premier-clinical-research-hub.html</guid>
		</item>	
				<item>
			<title>BioLineRx, Hemispherian to present GLIX1 ovarian cancer data at ESMO</title>
			<atom:link href="https://biospectrumasia.com/news/96/28071/biolinerx-hemispherian-to-present-glix1-ovarian-cancer-data-at-esmo.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28071/biolinerx-hemispherian-to-present-glix1-ovarian-cancer-data-at-esmo.html</link>
			<pubDate>Tue, 21 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/healthcare_cancer_10-28071.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28071/biolinerx-hemispherian-to-present-glix1-ovarian-cancer-data-at-esmo.html</guid>
		</item>	
				<item>
			<title>HUYABIO reports Phase 3 success for HBI-8000 in advanced melanoma</title>
			<atom:link href="https://biospectrumasia.com/news/96/28060/huyabio-reports-phase-3-success-for-hbi-8000-in-advanced-melanoma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28060/huyabio-reports-phase-3-success-for-hbi-8000-in-advanced-melanoma.html</link>
			<pubDate>Mon, 20 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images_9_-28060.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28060/huyabio-reports-phase-3-success-for-hbi-8000-in-advanced-melanoma.html</guid>
		</item>	
				<item>
			<title>Akeso launches US Phase II cadonilimab study in gastric cancer</title>
			<atom:link href="https://biospectrumasia.com/news/96/28062/akeso-launches-us-phase-ii-cadonilimab-study-in-gastric-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28062/akeso-launches-us-phase-ii-cadonilimab-study-in-gastric-cancer.html</link>
			<pubDate>Mon, 20 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/-28062.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28062/akeso-launches-us-phase-ii-cadonilimab-study-in-gastric-cancer.html</guid>
		</item>	
				<item>
			<title>Insmed reports 12-month TPIP data in pulmonary arterial hypertension</title>
			<atom:link href="https://biospectrumasia.com/news/96/28051/insmed-reports-12-month-tpip-data-in-pulmonary-arterial-hypertension.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28051/insmed-reports-12-month-tpip-data-in-pulmonary-arterial-hypertension.html</link>
			<pubDate>Fri, 17 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images_3_-28051.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28051/insmed-reports-12-month-tpip-data-in-pulmonary-arterial-hypertension.html</guid>
		</item>	
				<item>
			<title>Precision Medicine’s Next Decade Will Be Defined by Multi-Omics and AI</title>
			<atom:link href="https://biospectrumasia.com/influencers/96/28033/precision-medicines-next-decade-will-be-defined-by-multi-omics-and-ai.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/96/28033/precision-medicines-next-decade-will-be-defined-by-multi-omics-and-ai.html</link>
			<pubDate>Thu, 16 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hua_chien_chen_bio_asia_taiwan_under_400kb-28033.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/96/28033/precision-medicines-next-decade-will-be-defined-by-multi-omics-and-ai.html</guid>
		</item>	
				<item>
			<title>Lakewood-Amedex advances Nu-3 gel toward Phase 2a diabetic foot ulcer trial</title>
			<atom:link href="https://biospectrumasia.com/news/96/28038/lakewood-amedex-advances-nu-3-gel-toward-phase-2a-diabetic-foot-ulcer-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28038/lakewood-amedex-advances-nu-3-gel-toward-phase-2a-diabetic-foot-ulcer-trial.html</link>
			<pubDate>Thu, 16 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images_2_-28038.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28038/lakewood-amedex-advances-nu-3-gel-toward-phase-2a-diabetic-foot-ulcer-trial.html</guid>
		</item>	
				<item>
			<title>Maxona receives FDA IND clearance for non-opioid acute pain therapy</title>
			<atom:link href="https://biospectrumasia.com/news/96/28039/maxona-receives-fda-ind-clearance-for-non-opioid-acute-pain-therapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28039/maxona-receives-fda-ind-clearance-for-non-opioid-acute-pain-therapy.html</link>
			<pubDate>Thu, 16 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images_1_-28039.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28039/maxona-receives-fda-ind-clearance-for-non-opioid-acute-pain-therapy.html</guid>
		</item>	
				<item>
			<title>Kelun-Biotech reports Phase III success for sac-TMT combination in NSCLC</title>
			<atom:link href="https://biospectrumasia.com/news/96/28028/kelun-biotech-reports-phase-iii-success-for-sac-tmt-combination-in-nsclc.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28028/kelun-biotech-reports-phase-iii-success-for-sac-tmt-combination-in-nsclc.html</link>
			<pubDate>Wed, 15 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/epub_kelun_biotech_rendering_of_sacituzumab_tirumotecan_12_2_1200x635-28028.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28028/kelun-biotech-reports-phase-iii-success-for-sac-tmt-combination-in-nsclc.html</guid>
		</item>	
				<item>
			<title>Lynk completes Phase III enrolment for oral JAK1 inhibitor in ankylosing spondylitis</title>
			<atom:link href="https://biospectrumasia.com/news/96/28029/lynk-completes-phase-iii-enrolment-for-oral-jak1-inhibitor-in-ankylosing-spondylitis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28029/lynk-completes-phase-iii-enrolment-for-oral-jak1-inhibitor-in-ankylosing-spondylitis.html</link>
			<pubDate>Wed, 15 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ai_genetics_autoimmune_neurosicence-28029.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28029/lynk-completes-phase-iii-enrolment-for-oral-jak1-inhibitor-in-ankylosing-spondylitis.html</guid>
		</item>	
				<item>
			<title>Delonix doses first participant in China trial of MenB OMV vaccine</title>
			<atom:link href="https://biospectrumasia.com/news/96/28017/delonix-doses-first-participant-in-china-trial-of-menb-omv-vaccine.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28017/delonix-doses-first-participant-in-china-trial-of-menb-omv-vaccine.html</link>
			<pubDate>Tue, 14 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/index_img1_1_-28017.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28017/delonix-doses-first-participant-in-china-trial-of-menb-omv-vaccine.html</guid>
		</item>	
				<item>
			<title>MEDIPOST treats first US participant in Phase III stem cell therapy trial</title>
			<atom:link href="https://biospectrumasia.com/news/96/28018/medipost-treats-first-us-participant-in-phase-iii-stem-cell-therapy-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28018/medipost-treats-first-us-participant-in-phase-iii-stem-cell-therapy-trial.html</link>
			<pubDate>Tue, 14 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/01________ci_id_08d6da7b8162_logo-28018.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28018/medipost-treats-first-us-participant-in-phase-iii-stem-cell-therapy-trial.html</guid>
		</item>	
				<item>
			<title>Lynk doses first patient in Phase II vitiligo trial</title>
			<atom:link href="https://biospectrumasia.com/news/96/28019/lynk-doses-first-patient-in-phase-ii-vitiligo-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28019/lynk-doses-first-patient-in-phase-ii-vitiligo-trial.html</link>
			<pubDate>Tue, 14 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2026_07_11_13-28019.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28019/lynk-doses-first-patient-in-phase-ii-vitiligo-trial.html</guid>
		</item>	
				<item>
			<title>Cell Therapies supports Australian trial of A-SEEDS CAR-T therapy for solid tumours</title>
			<atom:link href="https://biospectrumasia.com/news/96/28000/cell-therapies-supports-australian-trial-of-a-seeds-car-t-therapy-for-solid-tumours.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/28000/cell-therapies-supports-australian-trial-of-a-seeds-car-t-therapy-for-solid-tumours.html</link>
			<pubDate>Fri, 10 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/celltherapies_inside_hood-28000.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/28000/cell-therapies-supports-australian-trial-of-a-seeds-car-t-therapy-for-solid-tumours.html</guid>
		</item>	
				<item>
			<title>West Synchrony prefillable syringe system available at CPHI Southeast Asia</title>
			<atom:link href="https://biospectrumasia.com/news/96/27991/west-synchrony-prefillable-syringe-system-available-at-cphi-southeast-asia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/27991/west-synchrony-prefillable-syringe-system-available-at-cphi-southeast-asia.html</link>
			<pubDate>Thu, 09 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/globallocationsbanner1-27991.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/27991/west-synchrony-prefillable-syringe-system-available-at-cphi-southeast-asia.html</guid>
		</item>	
				<item>
			<title>Insilico starts Phase III trial of AI-discovered IPF therapy</title>
			<atom:link href="https://biospectrumasia.com/news/96/27981/insilico-starts-phase-iii-trial-of-ai-discovered-ipf-therapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/27981/insilico-starts-phase-iii-trial-of-ai-discovered-ipf-therapy.html</link>
			<pubDate>Wed, 08 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images-27981.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/27981/insilico-starts-phase-iii-trial-of-ai-discovered-ipf-therapy.html</guid>
		</item>	
				<item>
			<title>FibroBiologics completes third cGMP batch for fibroblast therapy trial</title>
			<atom:link href="https://biospectrumasia.com/news/96/27982/fibrobiologics-completes-third-cgmp-batch-for-fibroblast-therapy-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/27982/fibrobiologics-completes-third-cgmp-batch-for-fibroblast-therapy-trial.html</link>
			<pubDate>Wed, 08 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images_3_-27982.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/27982/fibrobiologics-completes-third-cgmp-batch-for-fibroblast-therapy-trial.html</guid>
		</item>	
				<item>
			<title>Ascletis submits US IND applications for once-monthly obesity candidates</title>
			<atom:link href="https://biospectrumasia.com/news/96/27970/ascletis-submits-us-ind-applications-for-once-monthly-obesity-candidates.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/27970/ascletis-submits-us-ind-applications-for-once-monthly-obesity-candidates.html</link>
			<pubDate>Mon, 06 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cta_2_24_06_2026_-27970.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/27970/ascletis-submits-us-ind-applications-for-once-monthly-obesity-candidates.html</guid>
		</item>	
				<item>
			<title>Brii Bio reports Phase 2b chronic hepatitis B combination data</title>
			<atom:link href="https://biospectrumasia.com/news/96/27971/brii-bio-reports-phase-2b-chronic-hepatitis-b-combination-data.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/27971/brii-bio-reports-phase-2b-chronic-hepatitis-b-combination-data.html</link>
			<pubDate>Mon, 06 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/brii-27971.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/27971/brii-bio-reports-phase-2b-chronic-hepatitis-b-combination-data.html</guid>
		</item>	
				<item>
			<title>Viking starts Phase 1 trial of amylin-based weight-loss candidate</title>
			<atom:link href="https://biospectrumasia.com/news/96/27961/viking-starts-phase-1-trial-of-amylin-based-weight-loss-candidate.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/27961/viking-starts-phase-1-trial-of-amylin-based-weight-loss-candidate.html</link>
			<pubDate>Fri, 03 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/eb4bbad80120571d875800a6c4b0bcba-27961.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/27961/viking-starts-phase-1-trial-of-amylin-based-weight-loss-candidate.html</guid>
		</item>	
				<item>
			<title>Cryoport to support Verismo’s clinical KIR-CAR T cell therapy programmes</title>
			<atom:link href="https://biospectrumasia.com/news/96/27920/cryoport-to-support-verismos-clinical-kir-car-t-cell-therapy-programmes.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/27920/cryoport-to-support-verismos-clinical-kir-car-t-cell-therapy-programmes.html</link>
			<pubDate>Fri, 26 Jun 2026 13:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cryoport___logo-27920.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/27920/cryoport-to-support-verismos-clinical-kir-car-t-cell-therapy-programmes.html</guid>
		</item>	
				<item>
			<title>Servier enrols first US patient in rare paediatric epilepsy study</title>
			<atom:link href="https://biospectrumasia.com/news/96/27919/servier-enrols-first-us-patient-in-rare-paediatric-epilepsy-study.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/27919/servier-enrols-first-us-patient-in-rare-paediatric-epilepsy-study.html</link>
			<pubDate>Fri, 26 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/servier-27919.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/27919/servier-enrols-first-us-patient-in-rare-paediatric-epilepsy-study.html</guid>
		</item>	
				<item>
			<title>Innovative Molecules doses first patient in Phase 2a herpes trial</title>
			<atom:link href="https://biospectrumasia.com/news/96/27921/innovative-molecules-doses-first-patient-in-phase-2a-herpes-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/27921/innovative-molecules-doses-first-patient-in-phase-2a-herpes-trial.html</link>
			<pubDate>Fri, 26 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/innovative_molecules_logo-27921.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/27921/innovative-molecules-doses-first-patient-in-phase-2a-herpes-trial.html</guid>
		</item>	
				<item>
			<title>NeuroSense reports Phase 2 biomarker findings for PrimeC in Alzheimer’s disease</title>
			<atom:link href="https://biospectrumasia.com/news/96/27922/neurosense-reports-phase-2-biomarker-findings-for-primec-in-alzheimers-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/27922/neurosense-reports-phase-2-biomarker-findings-for-primec-in-alzheimers-disease.html</link>
			<pubDate>Fri, 26 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/logo_positive_horizontal_e1633873048940-27922.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/27922/neurosense-reports-phase-2-biomarker-findings-for-primec-in-alzheimers-disease.html</guid>
		</item>	
				<item>
			<title>Ollin raises $330M to advance Phase III retinal disease programme</title>
			<atom:link href="https://biospectrumasia.com/news/96/27913/ollin-raises-330m-to-advance-phase-iii-retinal-disease-programme.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/27913/ollin-raises-330m-to-advance-phase-iii-retinal-disease-programme.html</link>
			<pubDate>Thu, 25 Jun 2026 12:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/output_still_image_97aded4c_31b9_4999_9179_3ed7b49a16f4-27913.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/27913/ollin-raises-330m-to-advance-phase-iii-retinal-disease-programme.html</guid>
		</item>	
				<item>
			<title>CeleCor submits FDA application for investigational heart attack drug</title>
			<atom:link href="https://biospectrumasia.com/news/96/27911/celecor-submits-fda-application-for-investigational-heart-attack-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/27911/celecor-submits-fda-application-for-investigational-heart-attack-drug.html</link>
			<pubDate>Thu, 25 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/celecor_logo-27911.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/27911/celecor-submits-fda-application-for-investigational-heart-attack-drug.html</guid>
		</item>	
				<item>
			<title>Innovent doses first patient in Phase III tri-specific antibody trial</title>
			<atom:link href="https://biospectrumasia.com/news/96/27912/innovent-doses-first-patient-in-phase-iii-tri-specific-antibody-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/27912/innovent-doses-first-patient-in-phase-iii-tri-specific-antibody-trial.html</link>
			<pubDate>Thu, 25 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/20190319114710011_l-27912.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/27912/innovent-doses-first-patient-in-phase-iii-tri-specific-antibody-trial.html</guid>
		</item>	
				<item>
			<title>Breaking the Pain-Safety Trade-Off: The Promise of Dual NOP/MOP Agonists</title>
			<atom:link href="https://biospectrumasia.com/news/96/27873/breaking-the-pain-safety-trade-off-the-promise-of-dual-nop-mop-agonists.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/27873/breaking-the-pain-safety-trade-off-the-promise-of-dual-nop-mop-agonists.html</link>
			<pubDate>Tue, 23 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/james_hackworth_bio2026_under_400kb-27873.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/27873/breaking-the-pain-safety-trade-off-the-promise-of-dual-nop-mop-agonists.html</guid>
		</item>	
				<item>
			<title>Phanes completes Phase II enrolment for spevatamig in frontline pancreatic cancer</title>
			<atom:link href="https://biospectrumasia.com/news/96/27880/phanes-completes-phase-ii-enrolment-for-spevatamig-in-frontline-pancreatic-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/27880/phanes-completes-phase-ii-enrolment-for-spevatamig-in-frontline-pancreatic-cancer.html</link>
			<pubDate>Tue, 23 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/phanes_logo__png_logo-27880.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/27880/phanes-completes-phase-ii-enrolment-for-spevatamig-in-frontline-pancreatic-cancer.html</guid>
		</item>	
				<item>
			<title>Success Will Depend on the Ability to Operationalise AI, Not Just Adopt It</title>
			<atom:link href="https://biospectrumasia.com/influencers/96/27858/success-will-depend-on-the-ability-to-operationalise-ai-not-just-adopt-it.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/96/27858/success-will-depend-on-the-ability-to-operationalise-ai-not-just-adopt-it.html</link>
			<pubDate>Mon, 22 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/oliver_hampton_biospectrum_asia_under_400kb-27858.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/96/27858/success-will-depend-on-the-ability-to-operationalise-ai-not-just-adopt-it.html</guid>
		</item>	
				<item>
			<title>Beyond Checkpoint Inhibitors: Reimagining the Future of Cancer Immunotherapy</title>
			<atom:link href="https://biospectrumasia.com/influencers/96/27860/beyond-checkpoint-inhibitors-reimagining-the-future-of-cancer-immunotherapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/96/27860/beyond-checkpoint-inhibitors-reimagining-the-future-of-cancer-immunotherapy.html</link>
			<pubDate>Mon, 22 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/alex_shneider_biospectrum_asia_under_400kb-27860.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/96/27860/beyond-checkpoint-inhibitors-reimagining-the-future-of-cancer-immunotherapy.html</guid>
		</item>	
				<item>
			<title>Avance Clinical To Highlight Expanded APAC And China Operations At BIO 2026</title>
			<atom:link href="https://biospectrumasia.com/news/96/27844/avance-clinical-to-highlight-expanded-apac-and-china-operations-at-bio-2026.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/27844/avance-clinical-to-highlight-expanded-apac-and-china-operations-at-bio-2026.html</link>
			<pubDate>Fri, 19 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download-27844.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/27844/avance-clinical-to-highlight-expanded-apac-and-china-operations-at-bio-2026.html</guid>
		</item>	
				<item>
			<title>Insilico Begins Phase I Study of AI-Driven NLRP3 Inhibitor</title>
			<atom:link href="https://biospectrumasia.com/news/96/27835/insilico-begins-phase-i-study-of-ai-driven-nlrp3-inhibitor.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/27835/insilico-begins-phase-i-study-of-ai-driven-nlrp3-inhibitor.html</link>
			<pubDate>Thu, 18 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images_7_-27835.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/27835/insilico-begins-phase-i-study-of-ai-driven-nlrp3-inhibitor.html</guid>
		</item>	
				<item>
			<title>StemSight granted patent for scalable stem cell technology targeting corneal blindness</title>
			<atom:link href="https://biospectrumasia.com/news/96/27826/stemsight-granted-patent-for-scalable-stem-cell-technology-targeting-corneal-blindness.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/27826/stemsight-granted-patent-for-scalable-stem-cell-technology-targeting-corneal-blindness.html</link>
			<pubDate>Wed, 17 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1781605386_lab_work_wtn_1348-27826.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/27826/stemsight-granted-patent-for-scalable-stem-cell-technology-targeting-corneal-blindness.html</guid>
		</item>	
				<item>
			<title>FedEx Highlights Integrated Pharma Logistics Strategy for APAC at LogiPharma</title>
			<atom:link href="https://biospectrumasia.com/news/96/27827/fedex-highlights-integrated-pharma-logistics-strategy-for-apac-at-logipharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/27827/fedex-highlights-integrated-pharma-logistics-strategy-for-apac-at-logipharma.html</link>
			<pubDate>Wed, 17 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fedex_pharma_cargo-27827.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/27827/fedex-highlights-integrated-pharma-logistics-strategy-for-apac-at-logipharma.html</guid>
		</item>	
				<item>
			<title>Niowave, Ratio Therapeutics Sign Actinium-225 Supply Agreement to Advance Targeted Alpha Therapies</title>
			<atom:link href="https://biospectrumasia.com/news/96/27828/niowave-ratio-therapeutics-sign-actinium-225-supply-agreement-to-advance-targeted-alpha-therapies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/27828/niowave-ratio-therapeutics-sign-actinium-225-supply-agreement-to-advance-targeted-alpha-therapies.html</link>
			<pubDate>Wed, 17 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ratiologo_clr_sansblock-27828.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/27828/niowave-ratio-therapeutics-sign-actinium-225-supply-agreement-to-advance-targeted-alpha-therapies.html</guid>
		</item>	
				<item>
			<title>Tang Prize Honours Three Cellular Immunotherapy Pioneers</title>
			<atom:link href="https://biospectrumasia.com/news/96/27830/tang-prize-honours-three-cellular-immunotherapy-pioneers.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/27830/tang-prize-honours-three-cellular-immunotherapy-pioneers.html</link>
			<pubDate>Wed, 17 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/steven_a__rosenberg_michel_sadelain_carl_h__june-27830.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/27830/tang-prize-honours-three-cellular-immunotherapy-pioneers.html</guid>
		</item>	
				<item>
			<title>Neurocrine Presents CRENESSITY Case Series in Rare CAH Subtype</title>
			<atom:link href="https://biospectrumasia.com/news/96/27819/neurocrine-presents-crenessity-case-series-in-rare-cah-subtype.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/27819/neurocrine-presents-crenessity-case-series-in-rare-cah-subtype.html</link>
			<pubDate>Tue, 16 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/crenessity-27819.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/27819/neurocrine-presents-crenessity-case-series-in-rare-cah-subtype.html</guid>
		</item>	
				<item>
			<title>Hillhurst Bio Doses First Subject in Phase 2a Parkinson’s Trial</title>
			<atom:link href="https://biospectrumasia.com/news/96/27820/hillhurst-bio-doses-first-subject-in-phase-2a-parkinsons-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/27820/hillhurst-bio-doses-first-subject-in-phase-2a-parkinsons-trial.html</link>
			<pubDate>Tue, 16 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hillhurst_bio_logo2-27820.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/27820/hillhurst-bio-doses-first-subject-in-phase-2a-parkinsons-trial.html</guid>
		</item>	
				<item>
			<title>Rznomics Reports Interim Data for RNA Gene Therapy in Recurrent Glioblastoma</title>
			<atom:link href="https://biospectrumasia.com/news/96/27809/rznomics-reports-interim-data-for-rna-gene-therapy-in-recurrent-glioblastoma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/27809/rznomics-reports-interim-data-for-rna-gene-therapy-in-recurrent-glioblastoma.html</link>
			<pubDate>Mon, 15 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images_3_-27809.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/27809/rznomics-reports-interim-data-for-rna-gene-therapy-in-recurrent-glioblastoma.html</guid>
		</item>	
				<item>
			<title>CARsgen Presents Allogeneic CAR-T Data for Blood Cancers at EHA 2026</title>
			<atom:link href="https://biospectrumasia.com/news/96/27810/carsgen-presents-allogeneic-car-t-data-for-blood-cancers-at-eha-2026.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/27810/carsgen-presents-allogeneic-car-t-data-for-blood-cancers-at-eha-2026.html</link>
			<pubDate>Mon, 15 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/carsgen_1920-27810.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/27810/carsgen-presents-allogeneic-car-t-data-for-blood-cancers-at-eha-2026.html</guid>
		</item>	
				<item>
			<title>Lundbeck Reports Phase II Data for Asedebart in Cushing’s Disease</title>
			<atom:link href="https://biospectrumasia.com/news/96/27811/lundbeck-reports-phase-ii-data-for-asedebart-in-cushings-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/27811/lundbeck-reports-phase-ii-data-for-asedebart-in-cushings-disease.html</link>
			<pubDate>Mon, 15 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/lundbeck_logo_rgb-27811.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/27811/lundbeck-reports-phase-ii-data-for-asedebart-in-cushings-disease.html</guid>
		</item>	
				<item>
			<title>Genentech Gains FDA Priority Review for Oral SERD in Early Breast Cancer</title>
			<atom:link href="https://biospectrumasia.com/news/96/27799/genentech-gains-fda-priority-review-for-oral-serd-in-early-breast-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/27799/genentech-gains-fda-priority-review-for-oral-serd-in-early-breast-cancer.html</link>
			<pubDate>Fri, 12 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/w_gen_02-27799.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/27799/genentech-gains-fda-priority-review-for-oral-serd-in-early-breast-cancer.html</guid>
		</item>	
				<item>
			<title>Nuvalent Gains FDA Priority Review for ALK-Positive NSCLC Candidate</title>
			<atom:link href="https://biospectrumasia.com/news/96/27792/nuvalent-gains-fda-priority-review-for-alk-positive-nsclc-candidate.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/27792/nuvalent-gains-fda-priority-review-for-alk-positive-nsclc-candidate.html</link>
			<pubDate>Thu, 11 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/nuvalent_og_image-27792.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/27792/nuvalent-gains-fda-priority-review-for-alk-positive-nsclc-candidate.html</guid>
		</item>	
				<item>
			<title>Pfizer Secures FDA Approval for Expanded Hympavzi Use in Hemophilia</title>
			<atom:link href="https://biospectrumasia.com/news/96/27784/pfizer-secures-fda-approval-for-expanded-hympavzi-use-in-hemophilia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/27784/pfizer-secures-fda-approval-for-expanded-hympavzi-use-in-hemophilia.html</link>
			<pubDate>Wed, 10 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/vertanical_min-27784.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/27784/pfizer-secures-fda-approval-for-expanded-hympavzi-use-in-hemophilia.html</guid>
		</item>	
				<item>
			<title>MEDIPOST Secures FDA Agreement for CARTISTEM Phase III Strategy in US</title>
			<atom:link href="https://biospectrumasia.com/news/96/27785/medipost-secures-fda-agreement-for-cartistem-phase-iii-strategy-in-us.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/27785/medipost-secures-fda-agreement-for-cartistem-phase-iii-strategy-in-us.html</link>
			<pubDate>Wed, 10 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images_2_-27785.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/27785/medipost-secures-fda-agreement-for-cartistem-phase-iii-strategy-in-us.html</guid>
		</item>	
				<item>
			<title>Sanofi Secures EU Approval for Subcutaneous Sarclisa in Multiple Myeloma</title>
			<atom:link href="https://biospectrumasia.com/news/96/27786/sanofi-secures-eu-approval-for-subcutaneous-sarclisa-in-multiple-myeloma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/27786/sanofi-secures-eu-approval-for-subcutaneous-sarclisa-in-multiple-myeloma.html</link>
			<pubDate>Wed, 10 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/211125_sanofi_logo_rgb-27786.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/27786/sanofi-secures-eu-approval-for-subcutaneous-sarclisa-in-multiple-myeloma.html</guid>
		</item>	
				<item>
			<title>Argo Biopharma to Present Updated Phase II Data for siRNA HAE Therapy at EAACI 2026</title>
			<atom:link href="https://biospectrumasia.com/news/96/27777/argo-biopharma-to-present-updated-phase-ii-data-for-sirna-hae-therapy-at-eaaci-2026.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/27777/argo-biopharma-to-present-updated-phase-ii-data-for-sirna-hae-therapy-at-eaaci-2026.html</link>
			<pubDate>Tue, 09 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1757041743797-27777.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/27777/argo-biopharma-to-present-updated-phase-ii-data-for-sirna-hae-therapy-at-eaaci-2026.html</guid>
		</item>	
				<item>
			<title>Lilly’s Oral GLP-1 Foundayo Shows Superior Phase III Diabetes Results</title>
			<atom:link href="https://biospectrumasia.com/news/96/27778/lillys-oral-glp-1-foundayo-shows-superior-phase-iii-diabetes-results.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/27778/lillys-oral-glp-1-foundayo-shows-superior-phase-iii-diabetes-results.html</link>
			<pubDate>Tue, 09 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/usa_lilly-27778.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/27778/lillys-oral-glp-1-foundayo-shows-superior-phase-iii-diabetes-results.html</guid>
		</item>	
				<item>
			<title>Hansa Biopharma Reports Positive European Post-Authorisation Data for Idefirix</title>
			<atom:link href="https://biospectrumasia.com/news/96/27763/hansa-biopharma-reports-positive-european-post-authorisation-data-for-idefirix.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/27763/hansa-biopharma-reports-positive-european-post-authorisation-data-for-idefirix.html</link>
			<pubDate>Mon, 08 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images_1_-27763.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/27763/hansa-biopharma-reports-positive-european-post-authorisation-data-for-idefirix.html</guid>
		</item>	
				<item>
			<title>Otsuka Reports Phase III Data Showing VOYXACT Preserved Kidney Function in IgA Nephropathy</title>
			<atom:link href="https://biospectrumasia.com/news/96/27765/otsuka-reports-phase-iii-data-showing-voyxact-preserved-kidney-function-in-iga-nephropathy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/27765/otsuka-reports-phase-iii-data-showing-voyxact-preserved-kidney-function-in-iga-nephropathy.html</link>
			<pubDate>Mon, 08 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/4634_pharma_research_6_8774-27765.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/27765/otsuka-reports-phase-iii-data-showing-voyxact-preserved-kidney-function-in-iga-nephropathy.html</guid>
		</item>	
				<item>
			<title>FDA Approves TREMFYA Label Expansion for Structural Joint Damage in Psoriatic Arthritis</title>
			<atom:link href="https://biospectrumasia.com/news/96/27756/fda-approves-tremfya-label-expansion-for-structural-joint-damage-in-psoriatic-arthritis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/27756/fda-approves-tremfya-label-expansion-for-structural-joint-damage-in-psoriatic-arthritis.html</link>
			<pubDate>Fri, 05 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/tremfya-27756.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/27756/fda-approves-tremfya-label-expansion-for-structural-joint-damage-in-psoriatic-arthritis.html</guid>
		</item>	
				<item>
			<title>SGS Acquires CMIC to Expand North American Bioanalytical Testing Capabilities</title>
			<atom:link href="https://biospectrumasia.com/news/96/27757/sgs-acquires-cmic-to-expand-north-american-bioanalytical-testing-capabilities.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/27757/sgs-acquires-cmic-to-expand-north-american-bioanalytical-testing-capabilities.html</link>
			<pubDate>Fri, 05 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sgs_life_sciences_laboratory_fairfield_copy_a_1_-27757.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/27757/sgs-acquires-cmic-to-expand-north-american-bioanalytical-testing-capabilities.html</guid>
		</item>	
				<item>
			<title>Omnix Medical Announces First Patients Dosed in Phase II Trial of Antimicrobial Lead Compound OMN6</title>
			<atom:link href="https://biospectrumasia.com/news/96/27744/omnix-medical-announces-first-patients-dosed-in-phase-ii-trial-of-antimicrobial-lead-compound-omn6.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/27744/omnix-medical-announces-first-patients-dosed-in-phase-ii-trial-of-antimicrobial-lead-compound-omn6.html</link>
			<pubDate>Thu, 04 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1780494921_omnix_medical-27744.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/27744/omnix-medical-announces-first-patients-dosed-in-phase-ii-trial-of-antimicrobial-lead-compound-omn6.html</guid>
		</item>	
				<item>
			<title>M42 and Arcera Partner to Advance Biopharma Localization and Next Generation Life Sciences in Abu Dhabi</title>
			<atom:link href="https://biospectrumasia.com/news/96/27745/m42-and-arcera-partner-to-advance-biopharma-localization-and-next-generation-life-sciences-in-abu-dhabi.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/27745/m42-and-arcera-partner-to-advance-biopharma-localization-and-next-generation-life-sciences-in-abu-dhabi.html</link>
			<pubDate>Thu, 04 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1780483436_m42_x_arcera-27745.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/27745/m42-and-arcera-partner-to-advance-biopharma-localization-and-next-generation-life-sciences-in-abu-dhabi.html</guid>
		</item>	
				<item>
			<title>CellProthera Prepares For Phase 3 Push As Regenerative Cardiology Moves Closer To Clinical Reality</title>
			<atom:link href="https://biospectrumasia.com/news/96/27723/cellprothera-prepares-for-phase-3-push-as-regenerative-cardiology-moves-closer-to-clinical-reality.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/27723/cellprothera-prepares-for-phase-3-push-as-regenerative-cardiology-moves-closer-to-clinical-reality.html</link>
			<pubDate>Mon, 01 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/f04dcfdb_bdae_49b1_b84d_252a6da20c7e-27723.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/27723/cellprothera-prepares-for-phase-3-push-as-regenerative-cardiology-moves-closer-to-clinical-reality.html</guid>
		</item>	
				<item>
			<title>PREMIA and Lind expand AI-powered clinical trial screening across Asia-Pacific</title>
			<atom:link href="https://biospectrumasia.com/news/96/27694/premia-and-lind-expand-ai-powered-clinical-trial-screening-across-asia-pacific.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/27694/premia-and-lind-expand-ai-powered-clinical-trial-screening-across-asia-pacific.html</link>
			<pubDate>Fri, 29 May 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_29_5_2026_124426_www_premia_inc_com-27694.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/27694/premia-and-lind-expand-ai-powered-clinical-trial-screening-across-asia-pacific.html</guid>
		</item>	
				<item>
			<title>SUANNUTRA USA Secures US Distribution Rights for TetraSOD</title>
			<atom:link href="https://biospectrumasia.com/news/96/27667/suannutra-usa-secures-us-distribution-rights-for-tetrasod.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/27667/suannutra-usa-secures-us-distribution-rights-for-tetrasod.html</link>
			<pubDate>Wed, 20 May 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fitoplancton_marino_departamento_i_d_1_-27667.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/27667/suannutra-usa-secures-us-distribution-rights-for-tetrasod.html</guid>
		</item>	
				<item>
			<title>Minghui Reports Phase I/II Data for MHB018A in Thyroid Eye Disease</title>
			<atom:link href="https://biospectrumasia.com/news/96/27818/minghui-reports-phase-i-ii-data-for-mhb018a-in-thyroid-eye-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/27818/minghui-reports-phase-i-ii-data-for-mhb018a-in-thyroid-eye-disease.html</link>
			<pubDate>Sat, 16 May 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images_5_-27818.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/27818/minghui-reports-phase-i-ii-data-for-mhb018a-in-thyroid-eye-disease.html</guid>
		</item>	
				<item>
			<title>Asia-Pacific Healthcare Systems Face Growing Pressure to Modernise Digital Infrastructure</title>
			<atom:link href="https://biospectrumasia.com/opinion/96/27623/asia-pacific-healthcare-systems-face-growing-pressure-to-modernise-digital-infrastructure.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/96/27623/asia-pacific-healthcare-systems-face-growing-pressure-to-modernise-digital-infrastructure.html</link>
			<pubDate>Tue, 12 May 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_2026_05_12_164824_1_-27623.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/96/27623/asia-pacific-healthcare-systems-face-growing-pressure-to-modernise-digital-infrastructure.html</guid>
		</item>	
				<item>
			<title>Expecto Health Science Partners with Neuratrial to Pioneer AI-Driven CRO Operating Model</title>
			<atom:link href="https://biospectrumasia.com/news/96/27470/expecto-health-science-partners-with-neuratrial-to-pioneer-ai-driven-cro-operating-model.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/27470/expecto-health-science-partners-with-neuratrial-to-pioneer-ai-driven-cro-operating-model.html</link>
			<pubDate>Wed, 08 Apr 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/neuratrial_and_expecto_health_sciences_strategic_partnership_-27470.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/27470/expecto-health-science-partners-with-neuratrial-to-pioneer-ai-driven-cro-operating-model.html</guid>
		</item>	
				<item>
			<title>Singapore Strengthens Its Position As A Trusted Hub For Global Biopharmaceutical Manufacturing</title>
			<atom:link href="https://biospectrumasia.com/news/96/27350/singapore-strengthens-its-position-as-a-trusted-hub-for-global-biopharmaceutical-manufacturing.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/27350/singapore-strengthens-its-position-as-a-trusted-hub-for-global-biopharmaceutical-manufacturing.html</link>
			<pubDate>Fri, 13 Mar 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pengfei_edb-27350.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/27350/singapore-strengthens-its-position-as-a-trusted-hub-for-global-biopharmaceutical-manufacturing.html</guid>
		</item>	
				<item>
			<title>GCCL and Medicover announce strategic collaboration to strengthen multinational clinical trial services</title>
			<atom:link href="https://biospectrumasia.com/news/96/27188/gccl-and-medicover-announce-strategic-collaboration-to-strengthen-multinational-clinical-trial-services.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/27188/gccl-and-medicover-announce-strategic-collaboration-to-strengthen-multinational-clinical-trial-services.html</link>
			<pubDate>Wed, 11 Feb 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_11_2_2026_18285_-27188.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/27188/gccl-and-medicover-announce-strategic-collaboration-to-strengthen-multinational-clinical-trial-services.html</guid>
		</item>	
				<item>
			<title>Korea&#039;s GCCL partners with OPIS to advance global clinical trial capabilities</title>
			<atom:link href="https://biospectrumasia.com/news/96/27097/koreas-gccl-partners-with-opis-to-advance-global-clinical-trial-capabilities.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/27097/koreas-gccl-partners-with-opis-to-advance-global-clinical-trial-capabilities.html</link>
			<pubDate>Fri, 16 Jan 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_16_1_2026_23527_-27097.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/27097/koreas-gccl-partners-with-opis-to-advance-global-clinical-trial-capabilities.html</guid>
		</item>	
				<item>
			<title>Curie Oncology and Oncoshot deploy AI-powered clinical research tools </title>
			<atom:link href="https://biospectrumasia.com/news/96/27012/curie-oncology-and-oncoshot-deploy-ai-powered-clinical-research-tools-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/27012/curie-oncology-and-oncoshot-deploy-ai-powered-clinical-research-tools-.html</link>
			<pubDate>Wed, 17 Dec 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_17_12_2025_12567_www_prnewswire_com-27012.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/27012/curie-oncology-and-oncoshot-deploy-ai-powered-clinical-research-tools-.html</guid>
		</item>	
				<item>
			<title>Zuellig Pharma opens state-of-the-art clinical trial support innovation centre in South Korea</title>
			<atom:link href="https://biospectrumasia.com/news/96/26948/zuellig-pharma-opens-state-of-the-art-clinical-trial-support-innovation-centre-in-south-korea.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/26948/zuellig-pharma-opens-state-of-the-art-clinical-trial-support-innovation-centre-in-south-korea.html</link>
			<pubDate>Mon, 01 Dec 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_1_12_2025_185954_www_zuelligpharma_com-26948.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/26948/zuellig-pharma-opens-state-of-the-art-clinical-trial-support-innovation-centre-in-south-korea.html</guid>
		</item>	
				<item>
			<title>NEXT Oncology expands to Japan in partnership with Kansai Medical University</title>
			<atom:link href="https://biospectrumasia.com/news/96/26845/next-oncology-expands-to-japan-in-partnership-with-kansai-medical-university.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/26845/next-oncology-expands-to-japan-in-partnership-with-kansai-medical-university.html</link>
			<pubDate>Thu, 06 Nov 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/next_onco-26845.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/26845/next-oncology-expands-to-japan-in-partnership-with-kansai-medical-university.html</guid>
		</item>	
				<item>
			<title>Eli Lilly Commits Over $1.2 Billion to Expand Puerto Rico Manufacturing Hub</title>
			<atom:link href="https://biospectrumasia.com/news/96/26803/eli-lilly-commits-over-1-2-billion-to-expand-puerto-rico-manufacturing-hub.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/26803/eli-lilly-commits-over-1-2-billion-to-expand-puerto-rico-manufacturing-hub.html</link>
			<pubDate>Wed, 29 Oct 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/eli_lilly_770x433-26803.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/26803/eli-lilly-commits-over-1-2-billion-to-expand-puerto-rico-manufacturing-hub.html</guid>
		</item>	
				<item>
			<title>Singapore&#039;s Raffles Medical Group partners with Gene Solutions to expand access to global cancer clinical trials</title>
			<atom:link href="https://biospectrumasia.com/news/96/26790/singapores-raffles-medical-group-partners-with-gene-solutions-to-expand-access-to-global-cancer-clinical-trials.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/26790/singapores-raffles-medical-group-partners-with-gene-solutions-to-expand-access-to-global-cancer-clinical-trials.html</link>
			<pubDate>Tue, 28 Oct 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_28_10_2025_93940_en_prnasia_com-26790.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/26790/singapores-raffles-medical-group-partners-with-gene-solutions-to-expand-access-to-global-cancer-clinical-trials.html</guid>
		</item>	
				<item>
			<title>Avance Clinical opens CoE to accelerate early phase biotech trials</title>
			<atom:link href="https://biospectrumasia.com/news/96/26774/avance-clinical-opens-coe-to-accelerate-early-phase-biotech-trials.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/26774/avance-clinical-opens-coe-to-accelerate-early-phase-biotech-trials.html</link>
			<pubDate>Thu, 23 Oct 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_23_10_2025_101541_www_avancecro_com-26774.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/26774/avance-clinical-opens-coe-to-accelerate-early-phase-biotech-trials.html</guid>
		</item>	
				<item>
			<title>AI Meets CRO: Expecto Health Science Partners with VertisPro to Overcome Patient Recruitment Challenges</title>
			<atom:link href="https://biospectrumasia.com/news/96/26532/ai-meets-cro-expecto-health-science-partners-with-vertispro-to-overcome-patient-recruitment-challenges.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/26532/ai-meets-cro-expecto-health-science-partners-with-vertispro-to-overcome-patient-recruitment-challenges.html</link>
			<pubDate>Mon, 25 Aug 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/expecto_health_science_ubuntu_research_collaborate_to_fast_track_global_biotech_breakthroughs_11zon-26532.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/26532/ai-meets-cro-expecto-health-science-partners-with-vertispro-to-overcome-patient-recruitment-challenges.html</guid>
		</item>	
				<item>
			<title>Australian clinical trials accelerate innovation by empowering digital unified platform approach </title>
			<atom:link href="https://biospectrumasia.com/news/96/26327/australian-clinical-trials-accelerate-innovation-by-empowering-digital-unified-platform-approach-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/26327/australian-clinical-trials-accelerate-innovation-by-empowering-digital-unified-platform-approach-.html</link>
			<pubDate>Thu, 10 Jul 2025 12:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medical_banner_with_doctor_holding_tablet_23_2149611236-26327.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/26327/australian-clinical-trials-accelerate-innovation-by-empowering-digital-unified-platform-approach-.html</guid>
		</item>	
				<item>
			<title>Verified Clinical Trials launches operations in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/96/26314/verified-clinical-trials-launches-operations-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/26314/verified-clinical-trials-launches-operations-in-japan.html</link>
			<pubDate>Tue, 08 Jul 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ct-26314.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/26314/verified-clinical-trials-launches-operations-in-japan.html</guid>
		</item>	
				<item>
			<title>Novatrials opens advanced Phase 1 clinical trials facility in Australia to meet global demand</title>
			<atom:link href="https://biospectrumasia.com/news/96/26203/novatrials-opens-advanced-phase-1-clinical-trials-facility-in-australia-to-meet-global-demand.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/26203/novatrials-opens-advanced-phase-1-clinical-trials-facility-in-australia-to-meet-global-demand.html</link>
			<pubDate>Mon, 16 Jun 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download-26203.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/26203/novatrials-opens-advanced-phase-1-clinical-trials-facility-in-australia-to-meet-global-demand.html</guid>
		</item>	
				<item>
			<title>Novo Nordisk raises clinical research standards to develop Thailand&#039;s health system and economy</title>
			<atom:link href="https://biospectrumasia.com/news/96/26169/novo-nordisk-raises-clinical-research-standards-to-develop-thailands-health-system-and-economy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/26169/novo-nordisk-raises-clinical-research-standards-to-develop-thailands-health-system-and-economy.html</link>
			<pubDate>Mon, 09 Jun 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1748511717_1_-26169.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/26169/novo-nordisk-raises-clinical-research-standards-to-develop-thailands-health-system-and-economy.html</guid>
		</item>	
				<item>
			<title>Telix Pharma establishes new operations in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/96/26155/telix-pharma-establishes-new-operations-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/26155/telix-pharma-establishes-new-operations-in-japan.html</link>
			<pubDate>Thu, 05 Jun 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/telix-26155.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/26155/telix-pharma-establishes-new-operations-in-japan.html</guid>
		</item>	
				<item>
			<title>Taiwan&#039;s KMUH inks MoU with AbbVie to accelerate global clinical trials and advance patient-centered innovation</title>
			<atom:link href="https://biospectrumasia.com/news/96/26146/taiwans-kmuh-inks-mou-with-abbvie-to-accelerate-global-clinical-trials-and-advance-patient-centered-innovation.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/26146/taiwans-kmuh-inks-mou-with-abbvie-to-accelerate-global-clinical-trials-and-advance-patient-centered-innovation.html</link>
			<pubDate>Tue, 03 Jun 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/s__300654601-26146.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/26146/taiwans-kmuh-inks-mou-with-abbvie-to-accelerate-global-clinical-trials-and-advance-patient-centered-innovation.html</guid>
		</item>	
				<item>
			<title>Teddy Laboratory forges new landscape in lab services collaboration in China</title>
			<atom:link href="https://biospectrumasia.com/news/96/26117/teddy-laboratory-forges-new-landscape-in-lab-services-collaboration-in-china.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/26117/teddy-laboratory-forges-new-landscape-in-lab-services-collaboration-in-china.html</link>
			<pubDate>Fri, 30 May 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_30_5_2025_173242_www_labconnect_com-26117.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/26117/teddy-laboratory-forges-new-landscape-in-lab-services-collaboration-in-china.html</guid>
		</item>	
				<item>
			<title>Targeting inflammation at the source: VX-01 aims to redefine NPDR treatment with first oral therapy</title>
			<atom:link href="https://biospectrumasia.com/news/96/26041/targeting-inflammation-at-the-source-vx-01-aims-to-redefine-npdr-treatment-with-first-oral-therapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/26041/targeting-inflammation-at-the-source-vx-01-aims-to-redefine-npdr-treatment-with-first-oral-therapy.html</link>
			<pubDate>Fri, 16 May 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/alek_vantage_bioscience-26041.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/26041/targeting-inflammation-at-the-source-vx-01-aims-to-redefine-npdr-treatment-with-first-oral-therapy.html</guid>
		</item>	
				<item>
			<title>Australia starts world-first immunotherapy trial to treat Type 1 diabetes</title>
			<atom:link href="https://biospectrumasia.com/news/96/25962/australia-starts-world-first-immunotherapy-trial-to-treat-type-1-diabetes.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/25962/australia-starts-world-first-immunotherapy-trial-to-treat-type-1-diabetes.html</link>
			<pubDate>Wed, 30 Apr 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/uq-25962.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/25962/australia-starts-world-first-immunotherapy-trial-to-treat-type-1-diabetes.html</guid>
		</item>	
				<item>
			<title>There are over 650 cell and gene therapy clinical trials underway in APAC region</title>
			<atom:link href="https://biospectrumasia.com/opinion/96/25791/there-are-over-650-cell-and-gene-therapy-clinical-trials-underway-in-apac-region-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/96/25791/there-are-over-650-cell-and-gene-therapy-clinical-trials-underway-in-apac-region-.html</link>
			<pubDate>Mon, 31 Mar 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/michael-25791.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/96/25791/there-are-over-650-cell-and-gene-therapy-clinical-trials-underway-in-apac-region-.html</guid>
		</item>	
				<item>
			<title>Novotech strengthens clinical trial capabilities in South Korea</title>
			<atom:link href="https://biospectrumasia.com/news/96/25747/novotech-strengthens-clinical-trial-capabilities-in-south-korea.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/25747/novotech-strengthens-clinical-trial-capabilities-in-south-korea.html</link>
			<pubDate>Wed, 19 Mar 2025 09:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ct-25747.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/25747/novotech-strengthens-clinical-trial-capabilities-in-south-korea.html</guid>
		</item>	
				<item>
			<title>Avance Clinical inks new partnerships to expand into Taiwan</title>
			<atom:link href="https://biospectrumasia.com/news/96/25737/avance-clinical-inks-new-partnerships-to-expand-into-taiwan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/25737/avance-clinical-inks-new-partnerships-to-expand-into-taiwan.html</link>
			<pubDate>Tue, 18 Mar 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ct-25737.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/25737/avance-clinical-inks-new-partnerships-to-expand-into-taiwan.html</guid>
		</item>	
				<item>
			<title>China Medical University Hospital Joins With AbbVie to Promote Innovative Clinical Trial Collaboration</title>
			<atom:link href="https://biospectrumasia.com/opinion/96/25716/china-medical-university-hospital-joins-with-abbvie-to-promote-innovative-clinical-trial-collaboration.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/96/25716/china-medical-university-hospital-joins-with-abbvie-to-promote-innovative-clinical-trial-collaboration.html</link>
			<pubDate>Thu, 13 Mar 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ab241220_10-25716.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/96/25716/china-medical-university-hospital-joins-with-abbvie-to-promote-innovative-clinical-trial-collaboration.html</guid>
		</item>	
				<item>
			<title>India explores development of joint research, clinical trials, and technology-driven solutions with Queensland</title>
			<atom:link href="https://biospectrumasia.com/news/96/25643/india-explores-development-of-joint-research-clinical-trials-and-technology-driven-solutions-with-queensland.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/25643/india-explores-development-of-joint-research-clinical-trials-and-technology-driven-solutions-with-queensland.html</link>
			<pubDate>Wed, 26 Feb 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/tiq_queensland_press_meet_at_bioasia_2025-25643.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/25643/india-explores-development-of-joint-research-clinical-trials-and-technology-driven-solutions-with-queensland.html</guid>
		</item>	
				<item>
			<title>First major licensing deal for an exosome therapeutics in Korea</title>
			<atom:link href="https://biospectrumasia.com/news/96/25610/first-major-licensing-deal-for-an-exosome-therapeutics-in-korea.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/25610/first-major-licensing-deal-for-an-exosome-therapeutics-in-korea.html</link>
			<pubDate>Thu, 20 Feb 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/exo-25610.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/25610/first-major-licensing-deal-for-an-exosome-therapeutics-in-korea.html</guid>
		</item>	
				<item>
			<title>Novotech inks MoU with Wonju Severance Christian Hospital to drive clinical research excellence in Korea</title>
			<atom:link href="https://biospectrumasia.com/news/96/25604/novotech-inks-mou-with-wonju-severance-christian-hospital-to-drive-clinical-research-excellence-in-korea.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/25604/novotech-inks-mou-with-wonju-severance-christian-hospital-to-drive-clinical-research-excellence-in-korea.html</link>
			<pubDate>Wed, 19 Feb 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cro-25604.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/25604/novotech-inks-mou-with-wonju-severance-christian-hospital-to-drive-clinical-research-excellence-in-korea.html</guid>
		</item>	
				<item>
			<title>OliX Pharma and Lilly to develop treatment for metabolic-associated steatohepatitis </title>
			<atom:link href="https://biospectrumasia.com/news/96/25553/olix-pharma-and-lilly-to-develop-treatment-for-metabolic-associated-steatohepatitis-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/25553/olix-pharma-and-lilly-to-develop-treatment-for-metabolic-associated-steatohepatitis-.html</link>
			<pubDate>Mon, 10 Feb 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/liver-25553.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/25553/olix-pharma-and-lilly-to-develop-treatment-for-metabolic-associated-steatohepatitis-.html</guid>
		</item>	
				<item>
			<title>Australia announces $20 M funding boost for childhood brain cancer research</title>
			<atom:link href="https://biospectrumasia.com/news/96/25529/australia-announces-20-m-funding-boost-for-childhood-brain-cancer-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/25529/australia-announces-20-m-funding-boost-for-childhood-brain-cancer-research.html</link>
			<pubDate>Mon, 03 Feb 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/brain-25529.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/25529/australia-announces-20-m-funding-boost-for-childhood-brain-cancer-research.html</guid>
		</item>	
				<item>
			<title>Australia Advances Cancer Research with Kazia&#039;s ABC-Pax Trial for Triple-Negative Breast Cancer</title>
			<atom:link href="https://biospectrumasia.com/news/96/25513/australia-advances-cancer-research-with-kazias-abc-pax-trial-for-triple-negative-breast-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/25513/australia-advances-cancer-research-with-kazias-abc-pax-trial-for-triple-negative-breast-cancer.html</link>
			<pubDate>Fri, 31 Jan 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/breast_cancer-25513.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/25513/australia-advances-cancer-research-with-kazias-abc-pax-trial-for-triple-negative-breast-cancer.html</guid>
		</item>	
				<item>
			<title>When Clinical Trials Suffer From â€˜Complicated&#039; Interactions </title>
			<atom:link href="https://biospectrumasia.com/opinion/96/25524/when-clinical-trials-suffer-from-complicated-interactions-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/96/25524/when-clinical-trials-suffer-from-complicated-interactions-.html</link>
			<pubDate>Sat, 01 Feb 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/christine_senn_advarra_2024-25524.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/96/25524/when-clinical-trials-suffer-from-complicated-interactions-.html</guid>
		</item>	
				<item>
			<title>National Taiwan University Hospital and AbbVie Biopharma to strengthen digital strategies for clinical trials</title>
			<atom:link href="https://biospectrumasia.com/news/96/25417/national-taiwan-university-hospital-and-abbvie-biopharma-to-strengthen-digital-strategies-for-clinical-trials.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/25417/national-taiwan-university-hospital-and-abbvie-biopharma-to-strengthen-digital-strategies-for-clinical-trials.html</link>
			<pubDate>Fri, 10 Jan 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ntuh-25417.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/25417/national-taiwan-university-hospital-and-abbvie-biopharma-to-strengthen-digital-strategies-for-clinical-trials.html</guid>
		</item>	
				<item>
			<title>HiRO forges strategic partnership with CHA University Bundang Medical Center in South Korea</title>
			<atom:link href="https://biospectrumasia.com/news/96/25330/hiro-forges-strategic-partnership-with-cha-university-bundang-medical-center-in-south-korea.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/25330/hiro-forges-strategic-partnership-with-cha-university-bundang-medical-center-in-south-korea.html</link>
			<pubDate>Mon, 16 Dec 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mou-25330.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/25330/hiro-forges-strategic-partnership-with-cha-university-bundang-medical-center-in-south-korea.html</guid>
		</item>	
				<item>
			<title>â€œThe ongoing alignment of clinical trial regulations across APAC with global standards is significantâ€</title>
			<atom:link href="https://biospectrumasia.com/opinion/96/24984/the-ongoing-alignment-of-clinical-trial-regulations-across-apac-with-global-standards-is-significant.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/96/24984/the-ongoing-alignment-of-clinical-trial-regulations-across-apac-with-global-standards-is-significant.html</link>
			<pubDate>Wed, 02 Oct 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/anthony_costello-24984.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/96/24984/the-ongoing-alignment-of-clinical-trial-regulations-across-apac-with-global-standards-is-significant.html</guid>
		</item>	
				<item>
			<title>Fujitsu tackles â€˜drug loss&#039; in Japan through ecosystem to accelerate digitalization of clinical trials</title>
			<atom:link href="https://biospectrumasia.com/news/96/24775/fujitsu-tackles-drug-loss-in-japan-through-ecosystem-to-accelerate-digitalization-of-clinical-trials.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/24775/fujitsu-tackles-drug-loss-in-japan-through-ecosystem-to-accelerate-digitalization-of-clinical-trials.html</link>
			<pubDate>Mon, 26 Aug 2024 16:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/24775/fujitsu-tackles-drug-loss-in-japan-through-ecosystem-to-accelerate-digitalization-of-clinical-trials.html</guid>
		</item>	
				<item>
			<title>Uphill Task of Finding and Retaining Alzheimer&#039;s Study Participants</title>
			<atom:link href="https://biospectrumasia.com/opinion/96/24635/uphill-task-of-finding-and-retaining-alzheimers-study-participants.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/96/24635/uphill-task-of-finding-and-retaining-alzheimers-study-participants.html</link>
			<pubDate>Wed, 31 Jul 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cara_brant_ceo-24635.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/96/24635/uphill-task-of-finding-and-retaining-alzheimers-study-participants.html</guid>
		</item>	
				<item>
			<title>ObvioHealth announces strategic investment by Guardant Health to accelerate deployment of oncology clinical trials globally</title>
			<atom:link href="https://biospectrumasia.com/news/96/24624/obviohealth-announces-strategic-investment-by-guardant-health-to-accelerate-deployment-of-oncology-clinical-trials-globally.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/24624/obviohealth-announces-strategic-investment-by-guardant-health-to-accelerate-deployment-of-oncology-clinical-trials-globally.html</link>
			<pubDate>Thu, 25 Jul 2024 22:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/24624/obviohealth-announces-strategic-investment-by-guardant-health-to-accelerate-deployment-of-oncology-clinical-trials-globally.html</guid>
		</item>	
				<item>
			<title>Life Sciences Industry Faces Setbacks: The Impact of Failed Clinical Trials in 2024</title>
			<atom:link href="https://biospectrumasia.com/analysis/96/24503/life-sciences-industry-faces-setbacks-the-impact-of-failed-clinical-trials-in-2024.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/96/24503/life-sciences-industry-faces-setbacks-the-impact-of-failed-clinical-trials-in-2024.html</link>
			<pubDate>Fri, 28 Jun 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bsa-24503.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/96/24503/life-sciences-industry-faces-setbacks-the-impact-of-failed-clinical-trials-in-2024.html</guid>
		</item>	
				<item>
			<title>Immutep announces new collaboration with Merck</title>
			<atom:link href="https://biospectrumasia.com/news/96/24375/immutep-announces-new-collaboration-with-merck.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/24375/immutep-announces-new-collaboration-with-merck.html</link>
			<pubDate>Tue, 04 Jun 2024 10:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/24375/immutep-announces-new-collaboration-with-merck.html</guid>
		</item>	
				<item>
			<title>Evotec and CHDI Extend 20-Year Collaboration to Advance Huntington&#039;s Disease Therapeutics</title>
			<atom:link href="https://biospectrumasia.com/news/96/24339/evotec-and-chdi-extend-20-year-collaboration-to-advance-huntingtons-disease-therapeutics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/24339/evotec-and-chdi-extend-20-year-collaboration-to-advance-huntingtons-disease-therapeutics.html</link>
			<pubDate>Thu, 30 May 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images-24339.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/24339/evotec-and-chdi-extend-20-year-collaboration-to-advance-huntingtons-disease-therapeutics.html</guid>
		</item>	
				<item>
			<title>Australia launches new specialist ophthalmic clinical trial facility </title>
			<atom:link href="https://biospectrumasia.com/news/96/24276/australia-launches-new-specialist-ophthalmic-clinical-trial-facility-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/24276/australia-launches-new-specialist-ophthalmic-clinical-trial-facility-.html</link>
			<pubDate>Tue, 21 May 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_21_5_2024_114452_www_cera_org_au-24276.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/24276/australia-launches-new-specialist-ophthalmic-clinical-trial-facility-.html</guid>
		</item>	
				<item>
			<title>&quot;Japan&#039;s success in digital health is attributed to the collaborative efforts between the government, private sector, and academic institutions&quot;</title>
			<atom:link href="https://biospectrumasia.com/news/96/24271/japans-success-in-digital-health-is-attributed-to-the-collaborative-efforts-between-the-government-private-sector-and-academic-institutions.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/24271/japans-success-in-digital-health-is-attributed-to-the-collaborative-efforts-between-the-government-private-sector-and-academic-institutions.html</link>
			<pubDate>Mon, 20 May 2024 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dave-24271.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/24271/japans-success-in-digital-health-is-attributed-to-the-collaborative-efforts-between-the-government-private-sector-and-academic-institutions.html</guid>
		</item>	
				<item>
			<title>Singapore&#039;s SMART researchers identify malaria parasite drug resistance mechanism</title>
			<atom:link href="https://biospectrumasia.com/news/96/24256/singapores-smart-researchers-identify-malaria-parasite-drug-resistance-mechanism.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/24256/singapores-smart-researchers-identify-malaria-parasite-drug-resistance-mechanism.html</link>
			<pubDate>Fri, 17 May 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/8937bb_9e887aaafb3f47e0abd1711ff6caf670_mv2-24256.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/24256/singapores-smart-researchers-identify-malaria-parasite-drug-resistance-mechanism.html</guid>
		</item>	
				<item>
			<title>The Antibody-Drug Conjugate Community in Asia is Gearing Up for Their Annual Industry Touchpoint</title>
			<atom:link href="https://biospectrumasia.com/news/96/24264/the-antibody-drug-conjugate-community-in-asia-is-gearing-up-for-their-annual-industry-touchpoint.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/24264/the-antibody-drug-conjugate-community-in-asia-is-gearing-up-for-their-annual-industry-touchpoint.html</link>
			<pubDate>Wed, 15 May 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/24264/the-antibody-drug-conjugate-community-in-asia-is-gearing-up-for-their-annual-industry-touchpoint.html</guid>
		</item>	
				<item>
			<title>How APAC Has Turned into Clinical Trial Behemoth </title>
			<atom:link href="https://biospectrumasia.com/opinion/96/24151/how-apac-has-turned-into-clinical-trial-behemoth-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/96/24151/how-apac-has-turned-into-clinical-trial-behemoth-.html</link>
			<pubDate>Wed, 01 May 2024 11:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/m-24151.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/96/24151/how-apac-has-turned-into-clinical-trial-behemoth-.html</guid>
		</item>	
				<item>
			<title>What&#039;s APAC&#039;s Recipe of Success in Clinical Trials Market?</title>
			<atom:link href="https://biospectrumasia.com/analysis/96/24150/whats-apacs-recipe-of-success-in-clinical-trials-market.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/96/24150/whats-apacs-recipe-of-success-in-clinical-trials-market.html</link>
			<pubDate>Wed, 01 May 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bsa-24150.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/96/24150/whats-apacs-recipe-of-success-in-clinical-trials-market.html</guid>
		</item>	
				<item>
			<title>What Are the Main Challenges of Modern Clinical Trials?</title>
			<atom:link href="https://biospectrumasia.com/opinion/96/24152/what-are-the-main-challenges-of-modern-clinical-trials.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/96/24152/what-are-the-main-challenges-of-modern-clinical-trials.html</link>
			<pubDate>Wed, 01 May 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mark_weadon_global_analytics_product_marketing_manager_at_revvity_signals_-24152.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/96/24152/what-are-the-main-challenges-of-modern-clinical-trials.html</guid>
		</item>	
				<item>
			<title>â€œRegulatory encouragement of advanced tech, including AI will accelerate clinical trials in APACâ€</title>
			<atom:link href="https://biospectrumasia.com/opinion/96/24153/regulatory-encouragement-of-advanced-tech-including-ai-will-accelerate-clinical-trials-in-apac.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/96/24153/regulatory-encouragement-of-advanced-tech-including-ai-will-accelerate-clinical-trials-in-apac.html</link>
			<pubDate>Wed, 01 May 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/loka-24153.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/96/24153/regulatory-encouragement-of-advanced-tech-including-ai-will-accelerate-clinical-trials-in-apac.html</guid>
		</item>	
				<item>
			<title>â€œAustralia offers a simple, supportive and robust regulatory process to initiate human trials efficientlyâ€</title>
			<atom:link href="https://biospectrumasia.com/opinion/96/24154/australia-offers-a-simple-supportive-and-robust-regulatory-process-to-initiate-human-trials-efficiently.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/96/24154/australia-offers-a-simple-supportive-and-robust-regulatory-process-to-initiate-human-trials-efficiently.html</link>
			<pubDate>Wed, 01 May 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dr_pedro_garbes_vice_president_and_global_medical_lead_at_uvax_bio_-24154.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/96/24154/australia-offers-a-simple-supportive-and-robust-regulatory-process-to-initiate-human-trials-efficiently.html</guid>
		</item>	
				<item>
			<title>Merck inks a cancer deal with South Korea&#039;s Hanmi </title>
			<atom:link href="https://biospectrumasia.com/news/96/24123/merck-inks-a-cancer-deal-with-south-koreas-hanmi-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/24123/merck-inks-a-cancer-deal-with-south-koreas-hanmi-.html</link>
			<pubDate>Wed, 24 Apr 2024 15:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/24123/merck-inks-a-cancer-deal-with-south-koreas-hanmi-.html</guid>
		</item>	
				<item>
			<title>QUT partners with Omico to pave way for precision cancer care in Australia </title>
			<atom:link href="https://biospectrumasia.com/news/96/24103/qut-partners-with-omico-to-pave-way-for-precision-cancer-care-in-australia-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/24103/qut-partners-with-omico-to-pave-way-for-precision-cancer-care-in-australia-.html</link>
			<pubDate>Mon, 22 Apr 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer-24103.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/24103/qut-partners-with-omico-to-pave-way-for-precision-cancer-care-in-australia-.html</guid>
		</item>	
				<item>
			<title>Singapore supports development of AI-based clinical trial tool with S$50,000</title>
			<atom:link href="https://biospectrumasia.com/news/96/23997/singapore-supports-development-of-ai-based-clinical-trial-tool-with-s50000.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/23997/singapore-supports-development-of-ai-based-clinical-trial-tool-with-s50000.html</link>
			<pubDate>Wed, 27 Mar 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/nus-23997.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/23997/singapore-supports-development-of-ai-based-clinical-trial-tool-with-s50000.html</guid>
		</item>	
				<item>
			<title>ClinChoice acquires CSI, expanding global footprint into Southeast Asia</title>
			<atom:link href="https://biospectrumasia.com/news/96/23566/clinchoice-acquires-csi-expanding-global-footprint-into-southeast-asia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/23566/clinchoice-acquires-csi-expanding-global-footprint-into-southeast-asia.html</link>
			<pubDate>Fri, 12 Jan 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/clin-23566.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/23566/clinchoice-acquires-csi-expanding-global-footprint-into-southeast-asia.html</guid>
		</item>	
				<item>
			<title>Vietnam spearheads global trend in spore probiotics for respiratory health</title>
			<atom:link href="https://biospectrumasia.com/news/96/23409/vietnam-spearheads-global-trend-in-spore-probiotics-for-respiratory-health.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/23409/vietnam-spearheads-global-trend-in-spore-probiotics-for-respiratory-health.html</link>
			<pubDate>Thu, 30 Nov 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/23409/vietnam-spearheads-global-trend-in-spore-probiotics-for-respiratory-health.html</guid>
		</item>	
				<item>
			<title>CEPI, IVI and MRC Unit The Gambia to bolster clinical research capacity in West Africa to combat regional viral threat</title>
			<atom:link href="https://biospectrumasia.com/news/96/23400/cepi-ivi-and-mrc-unit-the-gambia-to-bolster-clinical-research-capacity-in-west-africa-to-combat-regional-viral-threat.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/23400/cepi-ivi-and-mrc-unit-the-gambia-to-bolster-clinical-research-capacity-in-west-africa-to-combat-regional-viral-threat.html</link>
			<pubDate>Thu, 30 Nov 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/4-23400.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/23400/cepi-ivi-and-mrc-unit-the-gambia-to-bolster-clinical-research-capacity-in-west-africa-to-combat-regional-viral-threat.html</guid>
		</item>	
				<item>
			<title>New antibiotic drug developed by HKU Chemistry research team approved for clinical trials in humans</title>
			<atom:link href="https://biospectrumasia.com/news/96/23148/new-antibiotic-drug-developed-by-hku-chemistry-research-team-approved-for-clinical-trials-in-humans.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/23148/new-antibiotic-drug-developed-by-hku-chemistry-research-team-approved-for-clinical-trials-in-humans.html</link>
			<pubDate>Wed, 11 Oct 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/23148/new-antibiotic-drug-developed-by-hku-chemistry-research-team-approved-for-clinical-trials-in-humans.html</guid>
		</item>	
				<item>
			<title>Japanese firm Mitsui invests $8 M in US-based clinical intelligence startup Lokavant</title>
			<atom:link href="https://biospectrumasia.com/news/96/23128/japanese-firm-mitsui-invests-8-m-in-us-based-clinical-intelligence-startup-lokavant.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/23128/japanese-firm-mitsui-invests-8-m-in-us-based-clinical-intelligence-startup-lokavant.html</link>
			<pubDate>Tue, 10 Oct 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ct-23128.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/23128/japanese-firm-mitsui-invests-8-m-in-us-based-clinical-intelligence-startup-lokavant.html</guid>
		</item>	
				<item>
			<title>China&#039;s BioCity Biopharm and AstraZeneca enter into collaboration agreement</title>
			<atom:link href="https://biospectrumasia.com/news/96/23074/chinas-biocity-biopharm-and-astrazeneca-enter-into-collaboration-agreement.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/23074/chinas-biocity-biopharm-and-astrazeneca-enter-into-collaboration-agreement.html</link>
			<pubDate>Fri, 29 Sep 2023 19:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/23074/chinas-biocity-biopharm-and-astrazeneca-enter-into-collaboration-agreement.html</guid>
		</item>	
				<item>
			<title>Korea to star trial for the world&#039;s first eyedrop treatment for diabetic retinopathy and macular edema</title>
			<atom:link href="https://biospectrumasia.com/news/96/23063/korea-to-star-trial-for-the-worlds-first-eyedrop-treatment-for-diabetic-retinopathy-and-macular-edema.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/23063/korea-to-star-trial-for-the-worlds-first-eyedrop-treatment-for-diabetic-retinopathy-and-macular-edema.html</link>
			<pubDate>Tue, 26 Sep 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/23063/korea-to-star-trial-for-the-worlds-first-eyedrop-treatment-for-diabetic-retinopathy-and-macular-edema.html</guid>
		</item>	
				<item>
			<title>Buzzreach and Oncoshot spearhead clinical trial advancements in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/96/23016/buzzreach-and-oncoshot-spearhead-clinical-trial-advancements-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/23016/buzzreach-and-oncoshot-spearhead-clinical-trial-advancements-in-japan.html</link>
			<pubDate>Thu, 14 Sep 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan-23016.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/23016/buzzreach-and-oncoshot-spearhead-clinical-trial-advancements-in-japan.html</guid>
		</item>	
				<item>
			<title>Australia shines in clinical trial activity ranking but gaps exist</title>
			<atom:link href="https://biospectrumasia.com/news/96/22881/australia-shines-in-clinical-trial-activity-ranking-but-gaps-exist.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/22881/australia-shines-in-clinical-trial-activity-ranking-but-gaps-exist.html</link>
			<pubDate>Fri, 18 Aug 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-22881.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/22881/australia-shines-in-clinical-trial-activity-ranking-but-gaps-exist.html</guid>
		</item>	
				<item>
			<title>Citeline appoints Clinrol as strategic clinical trial partner across APAC region</title>
			<atom:link href="https://biospectrumasia.com/news/96/22741/citeline-appoints-clinrol-as-strategic-clinical-trial-partner-across-apac-region.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/22741/citeline-appoints-clinrol-as-strategic-clinical-trial-partner-across-apac-region.html</link>
			<pubDate>Mon, 17 Jul 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/22741/citeline-appoints-clinrol-as-strategic-clinical-trial-partner-across-apac-region.html</guid>
		</item>	
				<item>
			<title>Why India Is Most Preferred Clinical Trials Destination</title>
			<atom:link href="https://biospectrumasia.com/opinion/96/22674/why-india-is-most-preferred-clinical-trials-destination.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/96/22674/why-india-is-most-preferred-clinical-trials-destination.html</link>
			<pubDate>Tue, 04 Jul 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/4-22674.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/96/22674/why-india-is-most-preferred-clinical-trials-destination.html</guid>
		</item>	
				<item>
			<title>Immuno-oncology company Biosyngen opens new cell therapy GMP facility in Singapore</title>
			<atom:link href="https://biospectrumasia.com/company-results/96/22654/immuno-oncology-company-biosyngen-opens-new-cell-therapy-gmp-facility-in-singapore.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/company-results/96/22654/immuno-oncology-company-biosyngen-opens-new-cell-therapy-gmp-facility-in-singapore.html</link>
			<pubDate>Wed, 28 Jun 2023 00:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/28_06_23_biosyngen_launch_ribbon_cutting-22654.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/company-results/96/22654/immuno-oncology-company-biosyngen-opens-new-cell-therapy-gmp-facility-in-singapore.html</guid>
		</item>	
				<item>
			<title>Australian startup Cyteph secures $1.5 M for brain cancer immunotherapy trial </title>
			<atom:link href="https://biospectrumasia.com/news/96/22506/australian-startup-cyteph-secures-1-5-m-for-brain-cancer-immunotherapy-trial-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/22506/australian-startup-cyteph-secures-1-5-m-for-brain-cancer-immunotherapy-trial-.html</link>
			<pubDate>Tue, 30 May 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_212432119-22506.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/22506/australian-startup-cyteph-secures-1-5-m-for-brain-cancer-immunotherapy-trial-.html</guid>
		</item>	
				<item>
			<title>PharmAbcine gets approval to initiate nAMD therapy in South Korea </title>
			<atom:link href="https://biospectrumasia.com/news/96/22507/pharmabcine-gets-approval-to-initiate-namd-therapy-in-south-korea-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/22507/pharmabcine-gets-approval-to-initiate-namd-therapy-in-south-korea-.html</link>
			<pubDate>Mon, 29 May 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/22507/pharmabcine-gets-approval-to-initiate-namd-therapy-in-south-korea-.html</guid>
		</item>	
				<item>
			<title>Singapore-based startup Hummingbird Bioscience inks oncology deal with Merck</title>
			<atom:link href="https://biospectrumasia.com/news/96/22451/singapore-based-startup-hummingbird-bioscience-inks-oncology-deal-with-merck.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/22451/singapore-based-startup-hummingbird-bioscience-inks-oncology-deal-with-merck.html</link>
			<pubDate>Wed, 17 May 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-22451.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/22451/singapore-based-startup-hummingbird-bioscience-inks-oncology-deal-with-merck.html</guid>
		</item>	
				<item>
			<title>EBPs are leveraging digitalisation to drive innovation and improve patient outcomes</title>
			<atom:link href="https://biospectrumasia.com/opinion/96/22408/ebps-are-leveraging-digitalisation-to-drive-innovation-and-improve-patient-outcomes.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/96/22408/ebps-are-leveraging-digitalisation-to-drive-innovation-and-improve-patient-outcomes.html</link>
			<pubDate>Fri, 05 May 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/jerome_armellini_asia_head_of_clinical_development_operations_strategy_r_d_solutions_asia_iqvia_asia_pacific-22408.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/96/22408/ebps-are-leveraging-digitalisation-to-drive-innovation-and-improve-patient-outcomes.html</guid>
		</item>	
				<item>
			<title>Japan bags new opportunity to improve healthcare system</title>
			<atom:link href="https://biospectrumasia.com/news/96/22011/japan-bags-new-opportunity-to-improve-healthcare-system.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/22011/japan-bags-new-opportunity-to-improve-healthcare-system.html</link>
			<pubDate>Mon, 27 Feb 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_231530785-22011.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/22011/japan-bags-new-opportunity-to-improve-healthcare-system.html</guid>
		</item>	
				<item>
			<title>Clinical program with the Lambert Initiative expands to include Avecho&#039;s oral cannabidiol</title>
			<atom:link href="https://biospectrumasia.com/news/96/21997/clinical-program-with-the-lambert-initiative-expands-to-include-avechos-oral-cannabidiol.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/21997/clinical-program-with-the-lambert-initiative-expands-to-include-avechos-oral-cannabidiol.html</link>
			<pubDate>Thu, 23 Feb 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/21997/clinical-program-with-the-lambert-initiative-expands-to-include-avechos-oral-cannabidiol.html</guid>
		</item>	
				<item>
			<title>3H Medi Solution to expand delivery of decentralized clinical trials in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/96/21987/3h-medi-solution-to-expand-delivery-of-decentralized-clinical-trials-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/21987/3h-medi-solution-to-expand-delivery-of-decentralized-clinical-trials-in-japan.html</link>
			<pubDate>Wed, 22 Feb 2023 22:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/21987/3h-medi-solution-to-expand-delivery-of-decentralized-clinical-trials-in-japan.html</guid>
		</item>	
				<item>
			<title>Groundbreaking trial underway for treatment of advanced Retinitis Pigmentosa in Australia</title>
			<atom:link href="https://biospectrumasia.com/news/96/21944/groundbreaking-trial-underway-for-treatment-of-advanced-retinitis-pigmentosa-in-australia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/21944/groundbreaking-trial-underway-for-treatment-of-advanced-retinitis-pigmentosa-in-australia.html</link>
			<pubDate>Wed, 15 Feb 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3-21944.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/21944/groundbreaking-trial-underway-for-treatment-of-advanced-retinitis-pigmentosa-in-australia.html</guid>
		</item>	
				<item>
			<title>Ph I trial of first needle-free influenza vaccine begins in Australia</title>
			<atom:link href="https://biospectrumasia.com/news/96/21929/ph-i-trial-of-first-needle-free-influenza-vaccine-begins-in-australia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/21929/ph-i-trial-of-first-needle-free-influenza-vaccine-begins-in-australia.html</link>
			<pubDate>Mon, 13 Feb 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/vax-21929.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/21929/ph-i-trial-of-first-needle-free-influenza-vaccine-begins-in-australia.html</guid>
		</item>	
				<item>
			<title>Korea&#039;s Wellmarker Bio inks cancer drug trial collaboration with Merck </title>
			<atom:link href="https://biospectrumasia.com/news/96/21911/koreas-wellmarker-bio-inks-cancer-drug-trial-collaboration-with-merck-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/21911/koreas-wellmarker-bio-inks-cancer-drug-trial-collaboration-with-merck-.html</link>
			<pubDate>Fri, 10 Feb 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-21911.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/21911/koreas-wellmarker-bio-inks-cancer-drug-trial-collaboration-with-merck-.html</guid>
		</item>	
				<item>
			<title>South Korea&#039;s GPCR Therapeutics launch US trial of cancer drug </title>
			<atom:link href="https://biospectrumasia.com/news/96/21782/south-koreas-gpcr-therapeutics-launch-us-trial-of-cancer-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/21782/south-koreas-gpcr-therapeutics-launch-us-trial-of-cancer-drug-.html</link>
			<pubDate>Tue, 17 Jan 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/21782/south-koreas-gpcr-therapeutics-launch-us-trial-of-cancer-drug-.html</guid>
		</item>	
				<item>
			<title>BC Platforms selected as partner to deliver key Singapore population health study</title>
			<atom:link href="https://biospectrumasia.com/news/96/21745/bc-platforms-selected-as-partner-to-deliver-key-singapore-population-health-study.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/21745/bc-platforms-selected-as-partner-to-deliver-key-singapore-population-health-study.html</link>
			<pubDate>Tue, 10 Jan 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/21745/bc-platforms-selected-as-partner-to-deliver-key-singapore-population-health-study.html</guid>
		</item>	
				<item>
			<title>CardieX &amp; Invaryant enable clinical trials with advanced new AI medical technology</title>
			<atom:link href="https://biospectrumasia.com/news/96/21709/cardiex-invaryant-enable-clinical-trials-with-advanced-new-ai-medical-technology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/21709/cardiex-invaryant-enable-clinical-trials-with-advanced-new-ai-medical-technology.html</link>
			<pubDate>Thu, 05 Jan 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-21709.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/21709/cardiex-invaryant-enable-clinical-trials-with-advanced-new-ai-medical-technology.html</guid>
		</item>	
				<item>
			<title>NZ-based P3 Research secures investment from Genesis Capital to accelerate expansion</title>
			<atom:link href="https://biospectrumasia.com/news/96/21665/nz-based-p3-research-secures-investment-from-genesis-capital-to-accelerate-expansion.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/21665/nz-based-p3-research-secures-investment-from-genesis-capital-to-accelerate-expansion.html</link>
			<pubDate>Fri, 23 Dec 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ct1-21665.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/21665/nz-based-p3-research-secures-investment-from-genesis-capital-to-accelerate-expansion.html</guid>
		</item>	
				<item>
			<title>Merck inks clinical trial deal with Zhejiang Doer Biologics</title>
			<atom:link href="https://biospectrumasia.com/news/96/21624/merck-inks-clinical-trial-deal-with-zhejiang-doer-biologics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/21624/merck-inks-clinical-trial-deal-with-zhejiang-doer-biologics.html</link>
			<pubDate>Fri, 16 Dec 2022 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/21624/merck-inks-clinical-trial-deal-with-zhejiang-doer-biologics.html</guid>
		</item>	
				<item>
			<title>New Zealand&#039;s health agencies explore ways to improve clinical trials</title>
			<atom:link href="https://biospectrumasia.com/news/96/21606/new-zealands-health-agencies-explore-ways-to-improve-clinical-trials.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/21606/new-zealands-health-agencies-explore-ways-to-improve-clinical-trials.html</link>
			<pubDate>Thu, 15 Dec 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/abstract_health_medical_science_healthcare_icon_36402_277-21606.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/21606/new-zealands-health-agencies-explore-ways-to-improve-clinical-trials.html</guid>
		</item>	
				<item>
			<title>Oncoshot and Novotech partner to offer cancer data insights in APAC</title>
			<atom:link href="https://biospectrumasia.com/news/96/21417/oncoshot-and-novotech-partner-to-offer-cancer-data-insights-in-apac.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/21417/oncoshot-and-novotech-partner-to-offer-cancer-data-insights-in-apac.html</link>
			<pubDate>Fri, 11 Nov 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/5-21417.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/21417/oncoshot-and-novotech-partner-to-offer-cancer-data-insights-in-apac.html</guid>
		</item>	
				<item>
			<title>Australia&#039;s Cynata to collaborate with Leiden University Medical Center (LUMC) in the Netherlands for kidney transplant</title>
			<atom:link href="https://biospectrumasia.com/news/96/21380/australias-cynata-to-collaborate-with-leiden-university-medical-center-lumc-in-the-netherlands-for-kidney-transplant.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/21380/australias-cynata-to-collaborate-with-leiden-university-medical-center-lumc-in-the-netherlands-for-kidney-transplant.html</link>
			<pubDate>Fri, 04 Nov 2022 15:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/21380/australias-cynata-to-collaborate-with-leiden-university-medical-center-lumc-in-the-netherlands-for-kidney-transplant.html</guid>
		</item>	
				<item>
			<title>South Korea&#039;s first  SGLT-2 inhibitor shows promising results in late stage trial </title>
			<atom:link href="https://biospectrumasia.com/news/96/21365/south-koreas-first-sglt-2-inhibitor-shows-promising-results-in-late-stage-trial-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/21365/south-koreas-first-sglt-2-inhibitor-shows-promising-results-in-late-stage-trial-.html</link>
			<pubDate>Wed, 02 Nov 2022 22:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/21365/south-koreas-first-sglt-2-inhibitor-shows-promising-results-in-late-stage-trial-.html</guid>
		</item>	
				<item>
			<title>Oracle to accelerate decentralized clinical trials in APAC</title>
			<atom:link href="https://biospectrumasia.com/news/96/21317/oracle-to-accelerate-decentralized-clinical-trials-in-apac.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/21317/oracle-to-accelerate-decentralized-clinical-trials-in-apac.html</link>
			<pubDate>Thu, 27 Oct 2022 11:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/21317/oracle-to-accelerate-decentralized-clinical-trials-in-apac.html</guid>
		</item>	
				<item>
			<title>Chinese startup Jacobio Pharma partners with Merck for cancer clinical trial</title>
			<atom:link href="https://biospectrumasia.com/news/96/21235/chinese-startup-jacobio-pharma-partners-with-merck-for-cancer-clinical-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/21235/chinese-startup-jacobio-pharma-partners-with-merck-for-cancer-clinical-trial.html</link>
			<pubDate>Fri, 14 Oct 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/5-21235.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/21235/chinese-startup-jacobio-pharma-partners-with-merck-for-cancer-clinical-trial.html</guid>
		</item>	
				<item>
			<title>Singapore pumps in SGD19.2 M for novel liver cancer treatment trial</title>
			<atom:link href="https://biospectrumasia.com/news/96/21185/singapore-pumps-in-sgd19-2-m-for-novel-liver-cancer-treatment-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/21185/singapore-pumps-in-sgd19-2-m-for-novel-liver-cancer-treatment-trial.html</link>
			<pubDate>Thu, 06 Oct 2022 01:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-21185.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/21185/singapore-pumps-in-sgd19-2-m-for-novel-liver-cancer-treatment-trial.html</guid>
		</item>	
				<item>
			<title>Asia Pacific takes lead in cell and gene clinical trials</title>
			<atom:link href="https://biospectrumasia.com/news/96/21055/asia-pacific-takes-lead-in-cell-and-gene-clinical-trials.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/21055/asia-pacific-takes-lead-in-cell-and-gene-clinical-trials.html</link>
			<pubDate>Thu, 15 Sep 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_160671770-21055.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/21055/asia-pacific-takes-lead-in-cell-and-gene-clinical-trials.html</guid>
		</item>	
				<item>
			<title>Alterity Therapeutics opens first site in Europe for drug trial of Multiple System Atrophy </title>
			<atom:link href="https://biospectrumasia.com/news/96/20928/alterity-therapeutics-opens-first-site-in-europe-for-drug-trial-of-multiple-system-atrophy-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/20928/alterity-therapeutics-opens-first-site-in-europe-for-drug-trial-of-multiple-system-atrophy-.html</link>
			<pubDate>Thu, 25 Aug 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3-20928.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/20928/alterity-therapeutics-opens-first-site-in-europe-for-drug-trial-of-multiple-system-atrophy-.html</guid>
		</item>	
				<item>
			<title>First central oncology laboratory for clinical trials opens in Malaysia</title>
			<atom:link href="https://biospectrumasia.com/news/96/20861/first-central-oncology-laboratory-for-clinical-trials-opens-in-malaysia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/20861/first-central-oncology-laboratory-for-clinical-trials-opens-in-malaysia.html</link>
			<pubDate>Thu, 11 Aug 2022 19:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/4-20861.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/20861/first-central-oncology-laboratory-for-clinical-trials-opens-in-malaysia.html</guid>
		</item>	
				<item>
			<title>Genesis Capital invests in Australian firm Crux Biolabs</title>
			<atom:link href="https://biospectrumasia.com/news/96/20829/genesis-capital-invests-in-australian-firm-crux-biolabs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/20829/genesis-capital-invests-in-australian-firm-crux-biolabs.html</link>
			<pubDate>Fri, 05 Aug 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-20829.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/20829/genesis-capital-invests-in-australian-firm-crux-biolabs.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Sosei partners with Cancer Research UK for cancer trials   </title>
			<atom:link href="https://biospectrumasia.com/news/96/20739/japans-sosei-partners-with-cancer-research-uk-for-cancer-trials-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/20739/japans-sosei-partners-with-cancer-research-uk-for-cancer-trials-.html</link>
			<pubDate>Fri, 22 Jul 2022 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/20739/japans-sosei-partners-with-cancer-research-uk-for-cancer-trials-.html</guid>
		</item>	
				<item>
			<title>Aculys Pharma, SUSMED to conduct world&#039;s first clinical trial using blockchain</title>
			<atom:link href="https://biospectrumasia.com/news/96/20685/aculys-pharma-susmed-to-conduct-worlds-first-clinical-trial-using-blockchain.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/20685/aculys-pharma-susmed-to-conduct-worlds-first-clinical-trial-using-blockchain.html</link>
			<pubDate>Wed, 13 Jul 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_133503068-20685.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/20685/aculys-pharma-susmed-to-conduct-worlds-first-clinical-trial-using-blockchain.html</guid>
		</item>	
				<item>
			<title>Alterity Therapeutics launches phase 2 trial of its orphan drug </title>
			<atom:link href="https://biospectrumasia.com/news/96/20439/alterity-therapeutics-launches-phase-2-trial-of-its-orphan-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/20439/alterity-therapeutics-launches-phase-2-trial-of-its-orphan-drug-.html</link>
			<pubDate>Mon, 06 Jun 2022 13:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/20439/alterity-therapeutics-launches-phase-2-trial-of-its-orphan-drug-.html</guid>
		</item>	
				<item>
			<title>Living Cell Technologies announces new agreement to use AI in trial</title>
			<atom:link href="https://biospectrumasia.com/news/96/20354/living-cell-technologies-announces-new-agreement-to-use-ai-in-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/20354/living-cell-technologies-announces-new-agreement-to-use-ai-in-trial.html</link>
			<pubDate>Tue, 24 May 2022 13:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/20354/living-cell-technologies-announces-new-agreement-to-use-ai-in-trial.html</guid>
		</item>	
				<item>
			<title>Singapore-based AUM Biosciences partners with Roche for cancer drug trial</title>
			<atom:link href="https://biospectrumasia.com/news/96/20265/singapore-based-aum-biosciences-partners-with-roche-for-cancer-drug-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/20265/singapore-based-aum-biosciences-partners-with-roche-for-cancer-drug-trial.html</link>
			<pubDate>Wed, 11 May 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_31369030-20265.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/20265/singapore-based-aum-biosciences-partners-with-roche-for-cancer-drug-trial.html</guid>
		</item>	
				<item>
			<title>Tetra partners with Cannvalate for clinical trials of Tetra&#039;s drug candidates in Australia</title>
			<atom:link href="https://biospectrumasia.com/news/96/20249/tetra-partners-with-cannvalate-for-clinical-trials-of-tetras-drug-candidates-in-australia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/20249/tetra-partners-with-cannvalate-for-clinical-trials-of-tetras-drug-candidates-in-australia.html</link>
			<pubDate>Mon, 09 May 2022 21:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/20249/tetra-partners-with-cannvalate-for-clinical-trials-of-tetras-drug-candidates-in-australia.html</guid>
		</item>	
				<item>
			<title>Claritas to begin Australian Trial </title>
			<atom:link href="https://biospectrumasia.com/news/96/20152/claritas-to-begin-australian-trial-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/20152/claritas-to-begin-australian-trial-.html</link>
			<pubDate>Mon, 25 Apr 2022 22:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/20152/claritas-to-begin-australian-trial-.html</guid>
		</item>	
				<item>
			<title>Korea&#039;s Genome and Company partners with Merck for cancer drug trial </title>
			<atom:link href="https://biospectrumasia.com/news/96/19780/koreas-genome-and-company-partners-with-merck-for-cancer-drug-trial-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/19780/koreas-genome-and-company-partners-with-merck-for-cancer-drug-trial-.html</link>
			<pubDate>Fri, 04 Mar 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/image-19780.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/19780/koreas-genome-and-company-partners-with-merck-for-cancer-drug-trial-.html</guid>
		</item>	
				<item>
			<title>World&#039;s first long-acting herpes treatment trial taking place in US, China</title>
			<atom:link href="https://biospectrumasia.com/news/96/19232/worlds-first-long-acting-herpes-treatment-trial-taking-place-in-us-china.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/19232/worlds-first-long-acting-herpes-treatment-trial-taking-place-in-us-china.html</link>
			<pubDate>Tue, 19 Oct 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screen_shot_2021_10_19_at_10_56_05_am-19232.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/19232/worlds-first-long-acting-herpes-treatment-trial-taking-place-in-us-china.html</guid>
		</item>	
				<item>
			<title>Anatara Lifesciences to launch First-of-its-kind Decentralized Clinical Trial in Australia</title>
			<atom:link href="https://biospectrumasia.com/news/96/19130/anatara-lifesciences-to-launch-first-of-its-kind-decentralized-clinical-trial-in-australia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/19130/anatara-lifesciences-to-launch-first-of-its-kind-decentralized-clinical-trial-in-australia.html</link>
			<pubDate>Thu, 30 Sep 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/close_up_doctor_is_showing_medical_analytics_data_medical_technology_concept_33799_5605-19130.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/19130/anatara-lifesciences-to-launch-first-of-its-kind-decentralized-clinical-trial-in-australia.html</guid>
		</item>	
				<item>
			<title>UK-based Futura Medical with OCT Clinical to run FM71 study in Eastern Europe, US</title>
			<atom:link href="https://biospectrumasia.com/news/96/19091/uk-based-futura-medical-with-oct-clinical-to-run-fm71-study-in-eastern-europe-us.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/19091/uk-based-futura-medical-with-oct-clinical-to-run-fm71-study-in-eastern-europe-us.html</link>
			<pubDate>Thu, 23 Sep 2021 14:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/research-19091.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/19091/uk-based-futura-medical-with-oct-clinical-to-run-fm71-study-in-eastern-europe-us.html</guid>
		</item>	
				<item>
			<title>UK Medical Research Council (MRC) grants Â£1.5 M to investigate Alzheimer&#039;s genetics</title>
			<atom:link href="https://biospectrumasia.com/news/96/19022/uk-medical-research-council-mrc-grants-1-5-m-to-investigate-alzheimers-genetics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/19022/uk-medical-research-council-mrc-grants-1-5-m-to-investigate-alzheimers-genetics.html</link>
			<pubDate>Mon, 13 Sep 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3d_medical_background_with_male_head_brain_dna_strands_1048_6346-19022.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/19022/uk-medical-research-council-mrc-grants-1-5-m-to-investigate-alzheimers-genetics.html</guid>
		</item>	
				<item>
			<title>China completes largest ever dry eye disease clinical trial </title>
			<atom:link href="https://biospectrumasia.com/news/96/18858/china-completes-largest-ever-dry-eye-disease-clinical-trial-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/18858/china-completes-largest-ever-dry-eye-disease-clinical-trial-.html</link>
			<pubDate>Thu, 19 Aug 2021 08:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/875676_eye_test_thinkstock_050117-18858.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/18858/china-completes-largest-ever-dry-eye-disease-clinical-trial-.html</guid>
		</item>	
				<item>
			<title>APAC sponsors/CROs inclination to innovative and optimized DCT model trial designs</title>
			<atom:link href="https://biospectrumasia.com/news/96/18756/apac-sponsors-cros-inclination-to-innovative-and-optimized-dct-model-trial-designs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/18756/apac-sponsors-cros-inclination-to-innovative-and-optimized-dct-model-trial-designs.html</link>
			<pubDate>Thu, 05 Aug 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/edwin_ng_medidata_solutions-18756.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/18756/apac-sponsors-cros-inclination-to-innovative-and-optimized-dct-model-trial-designs.html</guid>
		</item>	
				<item>
			<title>Longer-interval of Pfizer vaccine dose boosts antibody levels: Study</title>
			<atom:link href="https://biospectrumasia.com/news/96/18666/longer-interval-of-pfizer-vaccine-dose-boosts-antibody-levels-study.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/18666/longer-interval-of-pfizer-vaccine-dose-boosts-antibody-levels-study.html</link>
			<pubDate>Fri, 23 Jul 2021 19:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/syringe-18666.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/18666/longer-interval-of-pfizer-vaccine-dose-boosts-antibody-levels-study.html</guid>
		</item>	
				<item>
			<title>Nichi Glucan progresses to clinical studies in autism spectrum disorder</title>
			<atom:link href="https://biospectrumasia.com/opinion/96/18451/nichi-glucan-progresses-to-clinical-studies-in-autism-spectrum-disorder.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/96/18451/nichi-glucan-progresses-to-clinical-studies-in-autism-spectrum-disorder.html</link>
			<pubDate>Mon, 28 Jun 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download-18451.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/96/18451/nichi-glucan-progresses-to-clinical-studies-in-autism-spectrum-disorder.html</guid>
		</item>	
				<item>
			<title>eTheRNA, VUB expand collaboration to engineer next-generation mRNA therapeutics</title>
			<atom:link href="https://biospectrumasia.com/news/96/18428/etherna-vub-expand-collaboration-to-engineer-next-generation-mrna-therapeutics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/18428/etherna-vub-expand-collaboration-to-engineer-next-generation-mrna-therapeutics.html</link>
			<pubDate>Wed, 23 Jun 2021 16:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cell_research-18428.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/18428/etherna-vub-expand-collaboration-to-engineer-next-generation-mrna-therapeutics.html</guid>
		</item>	
				<item>
			<title>European Wellness, Li Hua Biotechnology alliance to boost China&#039;s clinical trials in fertility</title>
			<atom:link href="https://biospectrumasia.com/news/96/18419/european-wellness-li-hua-biotechnology-alliance-to-boost-chinas-clinical-trials-in-fertility.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/18419/european-wellness-li-hua-biotechnology-alliance-to-boost-chinas-clinical-trials-in-fertility.html</link>
			<pubDate>Tue, 22 Jun 2021 13:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/china-18419.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/18419/european-wellness-li-hua-biotechnology-alliance-to-boost-chinas-clinical-trials-in-fertility.html</guid>
		</item>	
				<item>
			<title>Medidata extends a secure platform for Decentralization of Clinical Trials (DCT)</title>
			<atom:link href="https://biospectrumasia.com/news/96/18380/medidata-extends-a-secure-platform-for-decentralization-of-clinical-trials-dct.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/18380/medidata-extends-a-secure-platform-for-decentralization-of-clinical-trials-dct.html</link>
			<pubDate>Wed, 16 Jun 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/freepikw4t-18380.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/18380/medidata-extends-a-secure-platform-for-decentralization-of-clinical-trials-dct.html</guid>
		</item>	
				<item>
			<title>Korea&#039;s IVI to develop adaptive Ph 1b/2a schistosomiasis vaccine trial</title>
			<atom:link href="https://biospectrumasia.com/news/96/18288/koreas-ivi-to-develop-adaptive-ph-1b-2a-schistosomiasis-vaccine-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/18288/koreas-ivi-to-develop-adaptive-ph-1b-2a-schistosomiasis-vaccine-trial.html</link>
			<pubDate>Thu, 03 Jun 2021 16:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_31369030-18288.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/18288/koreas-ivi-to-develop-adaptive-ph-1b-2a-schistosomiasis-vaccine-trial.html</guid>
		</item>	
				<item>
			<title>Tiziana seeks partner in Asia to enhance hepatocellular carcinoma treatment</title>
			<atom:link href="https://biospectrumasia.com/news/96/18130/tiziana-seeks-partner-in-asia-to-enhance-hepatocellular-carcinoma-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/18130/tiziana-seeks-partner-in-asia-to-enhance-hepatocellular-carcinoma-treatment.html</link>
			<pubDate>Wed, 05 May 2021 15:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_130099715-18130.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/18130/tiziana-seeks-partner-in-asia-to-enhance-hepatocellular-carcinoma-treatment.html</guid>
		</item>	
				<item>
			<title>China explores new mode of pharmaceutical R&amp;D </title>
			<atom:link href="https://biospectrumasia.com/news/96/18117/china-explores-new-mode-of-pharmaceutical-rd-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/18117/china-explores-new-mode-of-pharmaceutical-rd-.html</link>
			<pubDate>Mon, 03 May 2021 13:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_133503068-18117.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/18117/china-explores-new-mode-of-pharmaceutical-rd-.html</guid>
		</item>	
				<item>
			<title>Fujifilm initiates new Ph III trial of Avigan for COVID-19 treatment in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/96/18030/fujifilm-initiates-new-ph-iii-trial-of-avigan-for-covid-19-treatment-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/18030/fujifilm-initiates-new-ph-iii-trial-of-avigan-for-covid-19-treatment-in-japan.html</link>
			<pubDate>Wed, 21 Apr 2021 10:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_31369030-18030.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/18030/fujifilm-initiates-new-ph-iii-trial-of-avigan-for-covid-19-treatment-in-japan.html</guid>
		</item>	
				<item>
			<title>TrialWire launches StudyBoost, the Clinical trial insurance plan</title>
			<atom:link href="https://biospectrumasia.com/news/96/17823/trialwire-launches-studyboost-the-clinical-trial-insurance-plan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/17823/trialwire-launches-studyboost-the-clinical-trial-insurance-plan.html</link>
			<pubDate>Tue, 23 Mar 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/trialwire_650-17823.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/17823/trialwire-launches-studyboost-the-clinical-trial-insurance-plan.html</guid>
		</item>	
				<item>
			<title>UK conducts innovative COVID-19 trials with deliberate volunteered infection</title>
			<atom:link href="https://biospectrumasia.com/news/96/17694/uk-conducts-innovative-covid-19-trials-with-deliberate-volunteered-infection.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/17694/uk-conducts-innovative-covid-19-trials-with-deliberate-volunteered-infection.html</link>
			<pubDate>Tue, 02 Mar 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/coronavirus_covid_19_medical_test_vaccine_research_development_concept_31965_6475-17694.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/17694/uk-conducts-innovative-covid-19-trials-with-deliberate-volunteered-infection.html</guid>
		</item>	
				<item>
			<title>Panthera to evaluate AstraZeneca&#039;s AZD7442 for the potential prevention of COVID-19</title>
			<atom:link href="https://biospectrumasia.com/news/96/17344/panthera-to-evaluate-astrazenecas-azd7442-for-the-potential-prevention-of-covid-19.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/17344/panthera-to-evaluate-astrazenecas-azd7442-for-the-potential-prevention-of-covid-19.html</link>
			<pubDate>Wed, 30 Dec 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/top_view_doctor_holding_covid_vaccine_23_2148747841-17344.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/17344/panthera-to-evaluate-astrazenecas-azd7442-for-the-potential-prevention-of-covid-19.html</guid>
		</item>	
				<item>
			<title>Tychan to begin Ph 3 trial for mAb TY027 against COVID-19</title>
			<atom:link href="https://biospectrumasia.com/news/96/17266/tychan-to-begin-ph-3-trial-for-mab-ty027-against-covid-19.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/17266/tychan-to-begin-ph-3-trial-for-mab-ty027-against-covid-19.html</link>
			<pubDate>Mon, 14 Dec 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/covid_19_17610-17266.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/17266/tychan-to-begin-ph-3-trial-for-mab-ty027-against-covid-19.html</guid>
		</item>	
				<item>
			<title>Contract for innovative delivery system for COVID-19 vaccine</title>
			<atom:link href="https://biospectrumasia.com/news/96/17123/contract-for-innovative-delivery-system-for-covid-19-vaccine.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/17123/contract-for-innovative-delivery-system-for-covid-19-vaccine.html</link>
			<pubDate>Mon, 16 Nov 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_1183890526-17123.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/17123/contract-for-innovative-delivery-system-for-covid-19-vaccine.html</guid>
		</item>	
				<item>
			<title>CEPI funds Sichuan Clover for COVID-19 vaccine development</title>
			<atom:link href="https://biospectrumasia.com/news/96/17061/cepi-funds-sichuan-clover-for-covid-19-vaccine-development.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/17061/cepi-funds-sichuan-clover-for-covid-19-vaccine-development.html</link>
			<pubDate>Thu, 05 Nov 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutter-17061.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/17061/cepi-funds-sichuan-clover-for-covid-19-vaccine-development.html</guid>
		</item>	
				<item>
			<title>Russia- Destination of choice for Asian pharma companies</title>
			<atom:link href="https://biospectrumasia.com/opinion/96/17055/russia-destination-of-choice-for-asian-pharma-companies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/96/17055/russia-destination-of-choice-for-asian-pharma-companies.html</link>
			<pubDate>Tue, 03 Nov 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/picture1-17055.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/96/17055/russia-destination-of-choice-for-asian-pharma-companies.html</guid>
		</item>	
				<item>
			<title>Daewoong pharma partners with Tufts medical center for Ph 2  trial with Niclosamide</title>
			<atom:link href="https://biospectrumasia.com/news/96/17029/daewoong-pharma-partners-with-tufts-medical-center-for-ph-2-trial-with-niclosamide.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/17029/daewoong-pharma-partners-with-tufts-medical-center-for-ph-2-trial-with-niclosamide.html</link>
			<pubDate>Fri, 30 Oct 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstoc5k-17029.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/17029/daewoong-pharma-partners-with-tufts-medical-center-for-ph-2-trial-with-niclosamide.html</guid>
		</item>	
				<item>
			<title>Asieris announces approval for Ph 1 trial of bladder cancer drug in Australia</title>
			<atom:link href="https://biospectrumasia.com/news/96/17020/asieris-announces-approval-for-ph-1-trial-of-bladder-cancer-drug-in-australia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/17020/asieris-announces-approval-for-ph-1-trial-of-bladder-cancer-drug-in-australia.html</link>
			<pubDate>Thu, 29 Oct 2020 11:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pharma_shutter-17020.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/17020/asieris-announces-approval-for-ph-1-trial-of-bladder-cancer-drug-in-australia.html</guid>
		</item>	
				<item>
			<title>APRINOIA announces NMPA approval to initiate Ph 3 clinical trial</title>
			<atom:link href="https://biospectrumasia.com/news/96/17012/aprinoia-announces-nmpa-approval-to-initiate-ph-3-clinical-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/17012/aprinoia-announces-nmpa-approval-to-initiate-ph-3-clinical-trial.html</link>
			<pubDate>Wed, 28 Oct 2020 12:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_234792670-17012.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/17012/aprinoia-announces-nmpa-approval-to-initiate-ph-3-clinical-trial.html</guid>
		</item>	
				<item>
			<title>Evado is pleased to announce the launch of Evado OnDemand. </title>
			<atom:link href="https://biospectrumasia.com/news/96/16992/evado-is-pleased-to-announce-the-launch-of-evado-ondemand-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/16992/evado-is-pleased-to-announce-the-launch-of-evado-ondemand-.html</link>
			<pubDate>Mon, 26 Oct 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/evado_cloud_page-16992.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/16992/evado-is-pleased-to-announce-the-launch-of-evado-ondemand-.html</guid>
		</item>	
				<item>
			<title>Oric Pharma teams up with Korean firm to expand precision oncology pipeline</title>
			<atom:link href="https://biospectrumasia.com/news/96/16989/oric-pharma-teams-up-with-korean-firm-to-expand-precision-oncology-pipeline.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/16989/oric-pharma-teams-up-with-korean-firm-to-expand-precision-oncology-pipeline.html</link>
			<pubDate>Fri, 23 Oct 2020 12:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/clinical_trial-16989.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/16989/oric-pharma-teams-up-with-korean-firm-to-expand-precision-oncology-pipeline.html</guid>
		</item>	
				<item>
			<title>Astellas to present new roxadustat data in anemia of CKD at ASN kidney week </title>
			<atom:link href="https://biospectrumasia.com/news/96/16954/astellas-to-present-new-roxadustat-data-in-anemia-of-ckd-at-asn-kidney-week-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/16954/astellas-to-present-new-roxadustat-data-in-anemia-of-ckd-at-asn-kidney-week-.html</link>
			<pubDate>Mon, 19 Oct 2020 12:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterst-16954.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/16954/astellas-to-present-new-roxadustat-data-in-anemia-of-ckd-at-asn-kidney-week-.html</guid>
		</item>	
				<item>
			<title>Astellas, Seagen announce positive results in Ph 2 pivotal trial of PADCEV</title>
			<atom:link href="https://biospectrumasia.com/news/96/16922/astellas-seagen-announce-positive-results-in-ph-2-pivotal-trial-of-padcev.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/16922/astellas-seagen-announce-positive-results-in-ph-2-pivotal-trial-of-padcev.html</link>
			<pubDate>Wed, 14 Oct 2020 18:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan_pharma-16922.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/16922/astellas-seagen-announce-positive-results-in-ph-2-pivotal-trial-of-padcev.html</guid>
		</item>	
				<item>
			<title>MVC obtains Taiwan government subsidy for initiating Ph 1 trial of COVID-19 vaccine</title>
			<atom:link href="https://biospectrumasia.com/news/96/16911/mvc-obtains-taiwan-government-subsidy-for-initiating-ph-1-trial-of-covid-19-vaccine.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/16911/mvc-obtains-taiwan-government-subsidy-for-initiating-ph-1-trial-of-covid-19-vaccine.html</link>
			<pubDate>Tue, 13 Oct 2020 16:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pharma-16911.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/16911/mvc-obtains-taiwan-government-subsidy-for-initiating-ph-1-trial-of-covid-19-vaccine.html</guid>
		</item>	
				<item>
			<title>MedAlliance enrolls first two patients in PRISTINE study </title>
			<atom:link href="https://biospectrumasia.com/news/96/16899/medalliance-enrolls-first-two-patients-in-pristine-study-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/16899/medalliance-enrolls-first-two-patients-in-pristine-study-.html</link>
			<pubDate>Mon, 12 Oct 2020 12:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pr_news_wire_2-16899.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/16899/medalliance-enrolls-first-two-patients-in-pristine-study-.html</guid>
		</item>	
				<item>
			<title>Transgene, NEC, BostonGene collaborate for ovarian and head &amp; neck cancers trials</title>
			<atom:link href="https://biospectrumasia.com/news/96/16873/transgene-nec-bostongene-collaborate-for-ovarian-and-head-neck-cancers-trials.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/16873/transgene-nec-bostongene-collaborate-for-ovarian-and-head-neck-cancers-trials.html</link>
			<pubDate>Wed, 07 Oct 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/molecular_biologist_works_lab_87646_4184-16873.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/16873/transgene-nec-bostongene-collaborate-for-ovarian-and-head-neck-cancers-trials.html</guid>
		</item>	
				<item>
			<title>Can-Fite announces positive ph III psoriasis interim data analysis</title>
			<atom:link href="https://biospectrumasia.com/news/96/16863/can-fite-announces-positive-ph-iii-psoriasis-interim-data-analysis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/96/16863/can-fite-announces-positive-ph-iii-psoriasis-interim-data-analysis.html</link>
			<pubDate>Tue, 06 Oct 2020 17:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/psoriasis-16863.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/96/16863/can-fite-announces-positive-ph-iii-psoriasis-interim-data-analysis.html</guid>
		</item>	
				</channel>
</rss>
